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Ultrasound contrast agents (UCA) have tremendous potential for in vivo 
molecular imaging because of their high sensitivity and great spatial resolution of 
ultrasound imaging.  However, the diagnostic potential of UCAs has been difficult to 
exploit because current contrast agents are based on pre-formed microbubbles, which can 
only detect cell surface receptors.  In this work, we demonstrated that chemical reactions 
that generate gas forming molecules can be used to perform molecular imaging by 
ultrasound in vivo.  This new approach for generating ultrasound contrast agents was 
demonstrated by imaging reactive oxygen species (ROS) in vivo with allylhydrazine, a 
compound that is converted into nitrogen and propylene gas after reacting with radical 
oxidants (Scheme 1).  We demonstrated that allylhydrazine encapsulated within 
liposomes (termed APLs) can detect a 10 μM concentration of radical oxidants by 
ultrasound, and can image oxidative stress in mice, induced by lipopolysaccharide (LPS), 
using a clinical ultrasound machine.  We showed that a 1-2% increase in gas 
concentration above saturation can be detected acoustically and suggest that numerous 
biological targets can be imaged via appropriately designed gas forming reactions.  This 
work was the first demonstration of in vivo imaging of ROS using ultrasound, and this 
work presented a new strategy to generate gas bubbles from reactions involving radical 
oxidants.  We anticipate numerous applications of chemically generated microbubbles, 
given the excellent spatial resolution of ultrasound imaging, its widespread clinical use 








CHAPTER 1 SPECIFIC AIMS 
1.1 Introduction 
Conventional ultrasound contrast agents (UCA) are composed of preformed 
microbubbles conjugated with ligands that can bind to cell surface receptors.  However, 
the development of UCA that can image disease biomarkers remains a major challenge 
because many disease biomarkers are not expressed through the up-regulation of surface 
receptors.  Reactive oxygen species (ROS), for example, are disease biomarkers that are 
central to the development of inflammatory diseases, atherosclerosis and cardiovascular 
diseases.  Currently there are no contrast agents that can image ROS in a clinical setting.  
Hence, the ability to image ROS in vivo associated with inflammation, for example, 
would have translational impact on clinical diagnosis and early medical treatment.  
The overall objective of this thesis is to develop a new ultrasound contrast agent 
that has the physical and chemical properties needed to image ROS in vivo.  The central 
hypothesis is that ROS can be imaged by ultrasound in vivo via chemical reactions 
that generate gas bubbles in the presence of radical oxidants.  To accomplish this 
task, we will test our central hypothesis through the following three specific aims: 
 
1.2 Specific Aim I 
Design appropriate chemical reactions that can chemically generate gas bubbles in 
the presence of radical oxidants and characterize the in vitro acoustic response 
The objectives of this aim were to investigate the oxidation kinetics of various 
chemical reactions that generate gas forming molecules, and their in vitro acoustic 
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response.  Our working hypothesis was that allylhydrazine and its analogs can produce 
nitrogen gas molecules and nucleate gas bubbles under physiologically relevant 
concentrations of radical oxidants.  To accomplish this aim, several analogs of 
allylhydrazine were synthesized and their oxidation kinetics were characterized using 
various fluorescence spectroscopy assays.  We showed that the oxidation kinetics of 
allylhydrazine is suitable for bubble generation under physiological conditions. Both 
optical observation and acoustic characterization confirmed that the oxidation of 
allylhydrazine can nucleate gas bubbles.  A custom-built ultrasound system was used to 
study the effect of various ultrasound parameters on bubble nucleation, and the 
ultrasound parameters were optimized for bubble detection.  We found a linear 
correlation between the ultrasound intensity and the concentrations of radical oxidants.  
The outcomes of this Aim are described in Chapter 3 and 4. 
 
1.3 Specific Aim II 
Encapsulate allylhydrazine within liposomes to improve bubble stability and to 
enhance in vivo efficacy 
The objectives of this aim were to formulate the optimal liposome composition to 
encapsulate allylhydrazine for in vivo application.  Our working hypothesis was that 
encapsulating allylhydrazine within liposomes can improve the bubble stability and 
enhance the in vivo efficacy.  To accomplish this aim, we analyzed the effects of various 
liposome compositions on bubble nucleation, including lipid chain length, PEGlyation, 
incorporation of charged lipid and porphyrin, and lipid to allylhydrazine loading ratio.  
We characterized the acoustic response of allylhydrazine encapsulated within liposomes, 
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and we found that allylhydrazine encapsulated within liposomes displayed stronger 
ultrasound intensity than free allylhydrazine.  We also investigated the in vivo 
biodistribution of liposomes and we identified the liver as a suitable target organ for in 
vivo imaging.  The results of this Aim are described in Chapter 5. 
 
1.4 Specific Aim III 
Demonstrate in vivo imaging of oxidative stress using a clinical ultrasound system 
The objectives of this aim were to evaluate the feasibility of using allylhydrazine 
encapsulated within liposomes (APLs) to image oxidative stress in vivo with a clinical 
ultrasound system.  Our working hypothesis was that relative oxidative stress can be 
assessed using a lipopolysaccharide (LPS) endotoxin-induced inflammation model.  We 
first investigated an in vivo phantom experiment by direct local injection of 
allylhydrazine and hydroxyl radicals inside the intraperitoneal (IP) cavity of mice, and a 
clinical ultrasound system was used for imaging.  To image oxidative stress in vivo with 
ultrasound, LPS was injected into the IP cavity of mice to induce inflammation overnight, 
and the APLs were injected intravenously through the retro-orbital capillary.  We 
compared the ultrasound images of the liver from mice treated with LPS and the APLs 
versus mice treated with saline the APLs and we analyzed the video intensity in the 
region of interest.  We also used a clinical ultrasound contrast agent for comparison.  The 






Clinical ultrasound imaging provides non-invasive real-time imaging with good 
3D spatial resolution, and the application of ultrasound contrast agents for molecular 
imaging can enhance the diagnosis of many diseases.  Here, we presented a new strategy 
to create ultrasound contrast that can image ROS via chemically generated microbubbles.  
Since the overproduction of ROS are implicated in many diseases such as inflammation, 
atherosclerosis and cancer [1], the ability to image ROS in vivo can help clinicians 
diagnose diseases early.  Furthermore, classical theory predicts that bubble nucleation 
occurs at exceedingly high concentrations above gas supersaturation.  In this work, we 
showed that ultrasound can detect a 1-2% increase in gas concentration above saturation.  
Although many have reported that bubble nucleation can occur at much lower 
concentrations in the presence of pre-existing nuclei for bubble nucleation, using 
ultrasound to detect bubble nucleation is much more sensitive than previous methods 
with optical observation.  This approach opens up the development of new ultrasound 
contrasts, and numerous biological targets can be imaged via appropriately designed gas 
forming reactions.  We anticipate numerous applications of chemically generated 
microbubbles, given the excellent spatial resolution of ultrasound imaging, its widespread 
clinical use and its high sensitivity to detect gas bubbles. 
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CHAPTER 2 LITERATURE REVIEW 
2.1 Clinical ultrasound imaging and microbubble contrast agent 
Ultrasound is widely used for diagnostic imaging, and nearly 25% of all imaging 
studies worldwide are conducted by ultrasound examinations [2].  Ultrasound imaging is 
noninvasive, cost-effective, portable, and provides real-time imaging with good spatial 
and temporal resolution, allowing evaluation of dynamic physiological processes [3].  
Clinical examples include blood pool enhancement, characterization of liver lesions and 
perfusion imaging.  In certain clinical applications such as echocardiogram, ultrasound is 
the most cost-effective method compared to other modalities (MRI, CT or PET).  
Ultrasound has also been used to guide surgery such as radioactive seed implants in the 
prostate [4].  
In recent years, the introduction of microbubbles as contrast agents for ultrasound 
has greatly improved image quality and diagnostic value [5].  Microbubble contrast 
agents consist of a gas core (air or perfluorocarbon) which is stabilized by a shell 
(denatured albumin, phospholipid, or surfactant).  The principle behind using 
microbubbles as contrast agents is based on their compressibility.  Gas-containing 
microbubbles are 10,000 times more compressible than water or tissue.  This results in a 
very high echogenicity (up to 300 fold signal enhancement) such that the echo from an 
individual microbubble contrast agent can be detected by a clinical ultrasound system.  
The microbubble contrast agents behave hemodynamically like red blood cells (RBC).  
The unique properties of microbubbles as true intravascular tracers have enabled 
noninvasive measurements of microvascular perfusion in heart, brain, kidney, skeletal 
muscle, skin grafts, and solid tumors [6].   
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An ideal ultrasound contrast agent (UCA) should be non-toxic, injectable 
intravenously, capable of crossing pulmonary capillary bed (<10um) and stable enough to 
achieve enhancement during examination (few minutes) [7].  Microbubbles can also be 
directed selectively to specific vascular beds by conjugating targeting ligands (peptides, 
antibodies, aptamers) to their surface [8-9].  Molecular imaging with targeted 
microbubbles has been used for in vivo assessment of inflammation [10], angiogenesis 
[11-13], thrombus formation [14-15], tumor vasculature [16-18], and spleen infarctions 
[19-20].  Current targeted imaging with microbubble contrast agents are based on 
molecular recognition of ligands with cell receptor.  However, many disease biomarkers 
are not expressed through the up-regulation of surface receptors, and pre-formed gas 
bubbles cannot detect intracellular events. 
 
2.2 ROS and impact on human diseases 
Reactive oxygen species (ROS) are disease biomarkers and the overproduction of 
ROS is associated with many diseases including inflammation, atherosclerosis, 
cardiovascular disease, ischemia/reperfusion, and cancer.  The exact mechanisms and 
involvement of ROS in these diseases are not entirely known, and are the subject of 
intense research.  There is a strong correlation between ROS overproduction, oxidative 
stress, cellular damage and aging, and hence the maintenance of ROS level is essential to 
homeostasis [1, 21-22].  Figure 2.1 shows the role of ROS in normal physiology and the 



































Figure 2.1. The role of ROS in normal physiology and the development of diseases 
 
In the 1950s, Denham Harman first proposed the ‘free-radical theory’ of aging, 
speculating that endogenous oxygen radicals were generated in cells and resulted in a 
pattern of cumulative damage [23].  Later, the discovery of superoxide dismutase (SOD), 
an enzyme whose sole function is to convert superoxide anion into hydrogen peroxide 
provided strong support for Harman’s hypothesis [24].  Since then, the recognition of 
ROS led to the discovery of other reactive oxygen species and recent evidence indicates 
that ROS act as messengers in cellular signaling pathways that affect cell proliferation 
and/or cell death [21, 25]  
Most estimates suggest that the majority of intracellular ROS production occurs at 
the electron transport chain in the mitochondria [26-27].  During energy transduction, a 
small number of electrons “leak” to oxygen prematurely, forming the oxygen free radical 
superoxide [8, 28].  Measurements on submitochondrial particles suggest an upper limit 
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of 1-3% of all electrons in the transport chain “leaking” to generate superoxide [29].  
Superoxide species are very reactive and can be converted to hydroxyl radical (•OH) and 
various downstream reactive oxygen species.  As a result, these reactive oxygen species 
can cause damage to DNA, lipid and proteins [30-31]. 
 
2.3 Current technology and motivation for imaging ROS 
Despite the fact that ROS is a focus of intense research interest and thousands of 
papers have been published on this subject, there is a lack of imaging techniques to 
measure cellular ROS production in vivo.  Current methods to measure ROS 
quantitatively such as electron-spin-resonance (ESR) and HPLC require freezing the 
sample in liquid nitrogen or cumbersome sample preparation, which are not suitable for 
in vivo imaging.  Currently, the only practical method to image ROS is by fluorescence 
spectroscopy.  In fluorescence imaging, a fluorescent probe reacts with specific reactive 
oxygen species and the change in fluorescence intensity (at a detectable wavelength) is 
measured.  The advantage of fluorescence imaging includes high sensitivity (down to 
nanomolar concentration with some probes), specificity, and spatial resolution in 
microscopic imaging techniques [32].  Different probes have been developed for various 
reactive oxygen species [33].  However, fluorescence imaging has shallow penetration 
depth (< 1 cm) and poor spatial resolution, which presents a serious challenge for in vivo 
imaging of deep tissue or large animal in clinical applications.  Recently, a few 
fluorescent probes have been developed for in vivo imaging of ROS in small animals 
such as mice [34-36], but their applicability for in vivo imaging in large animals would 
require invasive procedure such as intravascular catheter or biopsy.  Other major issues 
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with these fluorescent probes include auto-oxidation, solubility, emission wavelength, 
and toxicity [33, 36].  To say the least, the limitations in current technology call for the 
development of new imaging modalities that can detect ROS in vivo non-invasively with 
high resolution, sensitivity, specificity and stability. 
 
2.4 Bubble nucleation from chemical reactions 
Our strategy is to detect ROS by ultrasound via chemical reactions that generate 
gas forming molecules in the presence of ROS.  Since the human body is saturated with 
nitrogen, an inert gas, chemical reactions that generate nitrogen or other inert gases 
would be suitable for in vivo imaging.  Furthermore, in order to generate gas bubbles 
chemically, the chemical reactions should be specific toward radical oxidants, sufficiently 
fast in clinical setting, and generate enough gas under physiological conditions that can 
be detected by ultrasound. 







, CO and NO in aqueous solutions and measured the rates of bubble nucleation 
respectively [37].  For bubble generation involving free radicals, Corey showed that 
allylic hydrazine can be oxidized, RNHNH
2 
→ RN=NH, followed by a 1,5-sigmatropic 
rearrangement of hydrogen with loss of nitrogen gas [38].  Sorenson proposed that 
allyldiazenes undergo intramolecular retro-ene reactions and showed that this is a 
concerted process involving a six-center cyclic transition state [39] (see Figure 2.2), 
although other mechanisms may be possible [40-43].  The oxidation rate of substituted 
hydrazines by superoxide ion (O
2
-·) has also been reported [44-48]. These studies 
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provided the understanding of how to design appropriate chemistry that can generate 
nitrogen gas from the reaction with free radicals. 
 
Figure 2.2. The mechanism of intramolecular retro-ene reaction of allylic hydrazine  
 
2.5 Classical bubble nucleation theory 
There have been many studies on bubble nucleation from supersaturated solutions 
and classical bubble nucleation theory predicts that homogeneous bubble nucleation 
should occur at exceedingly high concentrations above gas supersaturation [49-50].  In 
general, there are three ways to measure bubble nucleation.  First, reducing the external 
pressure below the vapor pressure of a pure liquid can cause cavitation.  Second, 
increasing the temperature until the vapor is more stable than a pure liquid can cause 
boiling.  Third, if a gas is dissolved in the liquid, then changing the conditions to create a 
supersaturated solution may nucleate gas bubbles.  The last scenario was often achieved 
by chemical generation of gas molecules, and experiments were designed to measure the 
supersaturation needed to cause appreciable nucleation.  The threshold for bubble 
nucleation was measured by optical observation [51]. 
Experimental evidence based on the first and second methods to measure bubble 
nucleation showed good agreement with theoretical prediction.  However, many reported 
that the threshold of bubble nucleation from gas forming reactions was much lower than 
theoretical prediction, and sometimes by as much as 2 orders of magnitude [52].  
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Furthermore, optical observations have limited sensitivity because it requires the observer 
to note the onset of bubble nucleation, and this means that the threshold for bubble 
nucleation could be even lower if more accurate methods are available.  Some 
explanations for the discrepancies between bubble nucleation theory and experimental 
results are due to the catalytic effect of hetero surfaces.  It has been shown that in the 
presence of pre-existing bubble nuclei, such as on the surfaces of the container or in the 
bulk solution, the energy required to nucleate bubble is much lower [51, 53], and 
therefore, bubble nucleation can occur at much lower concentrations. 
In the case of nitrogen, its solubility in water is 550 µM under standard condition 
(STP 1atm, 20oC) and 450 µM at 37oC [37].  The nitrogen gas concentration in the blood 
is nearly saturated (760 Torr x 0.78 x 8.42 x 10-7 mol/L·Torr = 500 µM), which suggests 
that, theoretically, increasing the nitrogen concentration by a small amount could exceed 
the nitrogen saturation in blood.  The lowest reported nitrogen concentration for 
homogeneous bubble nucleation is 10 mM, or 20 times above supersaturation [54]. 
 
2.6 Ultrasound detection of gas bubbles 
Ultrasound is extremely sensitive to gas bubbles and is capable of detecting 
individual micron-sized gas bubble with pico-liter (10-12 L) volume [55-57].  The reason 
is that microbubbles under an ultrasound field undergo volumetric oscillation and this 
vibration of the microbubbles produces a strong backscattered acoustic signal that can be 
detected and reproduced as an opacification on ultrasound imaging [58].  At low acoustic 
power (<100 kPa) these oscillations are linear and the frequency of the scattered signal is 
unaltered.  As the acoustic power increases (100 kPa – 1 MPa), non-linear interactions 
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occur because microbubbles resist compression more strongly than expansion.  
Microbubbles resonate (in the diagnostic range 1-20 MHz) and emit harmonic signal at 
multiples of the insonating frequency.  These harmonic signals are bubble-specific and 
can be used to distinguish scattered signal from tissue.  At even higher power (>1 MPa), 
highly non-linear behavior occurs with bubble destruction which can be coupled with 
specific detection modes to differentiate contrast signal from background [2].  Although 
ultrasound is very sensitive for detecting gas bubble, using ultrasound to measure bubble 
nucleation from chemical generation of gas molecules has not been reported. 
The behavior of free gas bubbles in solution has been studied over many years 
and is well understood [59].  Gas dissolved in liquid solution can nucleate, grow or 
dissolve back in solution [60].  On the other hand, the interaction between microbubbles 
and ultrasound beam is quite complex and requires specific signal processing to improve 
bubble detection (e.g. pulse inversion, harmonic imaging) [7].  Among the interactions 
between ultrasound and microbubbles, two phenomenon of particular interest are 
rectified diffusion and inertial cavitation.  In rectified diffusion, a bubble that would 
ordinarily dissolve in a liquid may increase in mass, rather than dissolve, if the amplitude 
of the pressure oscillations exceeds a certain threshold value [61].  Inertial cavitation 
occurs at very high acoustic field, when a bubble expands and collapses violently, 
generating heat and light (sonoluminescence). 
Microbubble-specific imaging sequences have been designed by varying imaging 
parameters such as the acoustic power, the transmit and receive frequencies, the pulse 
frequency, the pulse phase and amplitude.  Optimization of these parameters is required 
for different contrast agents to obtain the best diagnostic performance [62].  In recent 
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years, some people used optical methods to study bubble behavior under an ultrasound 
field.  They have demonstrated detection of single microbubble by ultrasound and 
verified optically.  For example, de Jong used a 100 MHz high speed camera to capture 
microbubble oscillation optically [63].  Ferrara captured both the optical and acoustical 
dynamics of microbubble inside neutrophil using similar methods [58, 64-65], and they 
investigated the interaction of microbubbles with the microvessel wall [66].  These 
advancements allow visualization and characterization of individual bubble behavior 
under an acoustic field. 
 
2.7 Liposomal encapsulation and stabilization of gas bubbles 
Maintaining bubble size is important because clinical ultrasound frequencies (1-
10 MHz) are optimized for bubble size between 1-5 µm.  However, free gas bubbles 
suspended in liquid can coalesce, grow or shrink [67].  Studies have shown that 
unencapsulated bubbles of the same size would disappear within a few seconds after 
having been introduced in the blood circulation.  This is because a free gas bubble has a 
finite surface tension, and Laplace overpressure exists that drives gas out even when the 
surrounding aqueous gas concentration is saturated [68-69].  On the other hand, gas 
encased in a solid lipid shell has essentially zero tension in the surface, can persist in this 
equilibrium state, and so is only constrained by the gas concentration in solution [70].  
The change in bubble size is determined by the mass transfer [71], and large bubbles (~ 
100 µm) change size relatively slowly due to gas saturation conditions or the Laplace 
pressure.  However, for smaller gas bubbles (~10 µm), the Laplace pressure is hundred 
times larger and the rate of volume change is easily measurable.  
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An effective way to slow down the dissolution of microbubble is to protect the 
microbubble with a shell at the gas-liquid interface.  The shell may be composed of 
protein [72], surfactant [73-75], polymer [76], or lipid [9, 77].  The advantage of using 
amphiphilic molecules as the coating material is that they self-assemble into a monolayer 
shell around the gas core [78], allowing better control of the shell surface architecture and 
greater flexibility when adding functional molecules [9].  Recently, it was discovered that 
phospholipid shells possess echogenic behavior [79-80], and they tend to reseal following 
surface rupture due to strong hydrophobic forces [81-82].  A lipid shell is also a better 
acoustic scatterer than a polymer shell because the polymer absorbs more acoustic 
energy.  In general, increasing hydrophobic chain length will make lipid-coated 
microbubbles more robust [83].  As the lipid monolayer becomes more cohesive with 
increasing acyl chain length, the permeability of the shell to gases decreases, leading to a 
more stable bubble.  Phospholipid with charged head group such as 1,2-Dipalmitoyl-sn-
glycero-3-phosphatidic acid (DPPA) can enhance bubble dispersion.  A hydrophilic 
polyethylene glycol (PEG) emulsifier can also be added to aid lipid dispersion and 
prevent microbubble coalescence [84].  These coatings can alter the elasticity and 
viscosity of the microbubble, and thereby change the resonant frequency of the 
microbubble and dampen the vibration. 
Another benefit of attaching PEG chains to the lipid shell is that these sterically 
stabilized molecules allow the liposome to escape macrophage phagocytosis and prolong 
circulation [85].  Therefore, the contrast agent material for ROS can be encapsulated 
inside PEGlyated liposome to enhance in vivo efficacy.  Several commercial FDA-
approved microbubble contrast agents are composed of phospholipid shells attached with 
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PEG chains [86].  Other surface modification allows attachment of specific ligands that 
promote cell adhesion and targeting.  Examples include attachment to activated 
leukocytes [10, 87-88], integrins [89] and ICAM-1 [90].  In summary, encapsulating the 
contrast agent inside the liposomes can improve bubble stability and enhance in vivo 
efficacy. 
 
2.8 In vivo imaging of oxidative stress 
ROS are overproduced in a variety of inflammatory diseases, including 
atherosclerosis, chronic obstructive pulmonary disease and liver hepatitis [36].  Contrast 
agents that can image ROS in vivo have the potential to significantly impact these areas 
of medicine and biology [91].  Hence, there is a great interest to determine if ROS 
imaging can be used as a diagnostic tool for inflammatory diseases.  For ultrasound 
imaging, several studies described the effectiveness of microbubble contrast agents 
particularly in the liver, spleen, and kidneys [2].  Microbubbles allow assessment of the 
macrovasculature, the identification and characterization of hepatic and splenic lesions, 
the depiction of septal enhancement in cystic renal masses, and the quantification of 
organ perfusion.  Even though microbubbles present a pure intravascular distribution, 
some agents present a post-vascular hepatosplenic specific phase from 2-5 minutes after 
intravenous injection [92-95]. The site of hepatic accumulation may be within the 
reticulo-endothelial system.  From a clinical perspective, the liver has been the abdominal 
organ that the contrast agents have provided the most reliable clinical results [2].  
Examples include characterization of portal vein patency in cirrhosis and liver 
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transplantation [96-98], liver lesions [94, 99-101], and hepatocellular carcinoma [99, 102-
103].  
Previous work in our lab demonstrated in vivo imaging of hydrogen peroxide 
based on a chemi-luminescent contrast agent [36].  In previous studies, a 
lipopolysaccharide-endotoxin (LPS) was injected into the intraperitoneal cavity of mice 
to induce inflammatory response, and the overproduction of hydrogen peroxide in the 
intraperitoneal cavity of mice was imaged in vivo using a fluorescence IVIS machine.  
The onset of inflammatory response and the recruitment of activated macrophages have 
been studied and confirmed to occur within 24 hours [104].  Therefore, the LPS-induced 
inflammatory response model could be used for similar studies by ultrasound. 
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CHAPTER 3  
CHEMICAL GAS GENERATION INVOLVING RADICAL 
OXIDANTS 
3.1 Introduction 
The objective of this aim is to evaluate the feasibility of using chemical reactions 
to generate gas forming molecules in the presence of radical oxidants and detect ROS.  
The first task is to design and synthesize appropriate molecules that can generate gas 
molecules in the presence of radical oxidants.  The second task is to characterize the 
chemical reactivity and the oxidation kinetics of the molecule after it has been designed. 
There are many chemical reactions that form gas molecules, such as H2 [105], N2 
[106], O2 [107], CO2 [108], disulfide [109] and NaBH4 [54].  Corey showed that allylic 
hydrazine can be oxidized by radical oxidants [38], and Sorenson showed that 
allyldiazenes undergo intramolecular retro-ene reactions to generate nitrogen and propene 
gas forming molecules [39].  Therefore, we anticipate allylhydrazine and its analogs 
could be potential molecules for this application.  We hypothesize that the reactivity of 
allylhydrazine with radical oxidants can be enhanced by adding methyl or fluorine group 
on the C2 position, and attaching long hydrocarbon chain could enhance its in vivo 
efficacy by forming a micelle. 
Theoretically, the kinetics of gas forming reaction needs to be faster than the rate 
of diffusion to exceed the critical threshold needed for bubble nucleation.  Hence, the 
second task is to investigate if allylhydrazine and its analogs can be oxidized by radical 
oxidants and to determine their oxidation kinetics.  The trinitrobenzene sulfonic acid 
(TNBS) and azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assays were used to 
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characterize the oxidation kinetics of allylhydrazine.  The TNBS assay has been used to 
determine the presence of primary amine in proteins.  The ABTS assay is used to 
determine the rate of oxidation, and hence the kinetics of free radicals reacting with 
allylhydrazine.  This assay is based upon the ability of antioxidants to decolorize the 
ABTS radical cation. 
 
3.2 Materials and Methods 
3.2.1 Allylhydrazine and synthesis of allylhydrazine analogs 
Preparation of allylhydrazine 
Allylhydrazine • 2 HCl was purchased from ECA International Corporation 
(Palatine, IL) and neutralized with NaOH to pH ~7.4 prior to use. 
 
Synthesis of 2-fluoroallyl-hydrazine 
10.00 g (0.043 mol) of N,N’-di-Boc-hydrazine, 11.87 g (2 equiv) of K2CO3, 6.03 
g (3.5 equiv) of NaOH and 1.466 g (0.1 equiv) of TBAHS were dissolved in 160 mL of 
toluene and 3.9 mL of 2-fluoro-3-chloro-propene (1.05 equiv) dissolved in 15 mL of 
toluene was added dropwise at 20 mL/hr rate into the reaction mixture.  The reaction was 
conducted at room temperature and stirred overnight.  Thin Layer Chromatography 
(TLC) analysis was used to monitor the formation of product.  Toluene was removed by a 
rotovap and 40 mL of water was added to the mixture and the organic phase was 
extracted 4 times with 80 mL of EtOAc, dried with Na2SO4 and separated by column 
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chromatography.  The di-tert-butyl 1-(2-fluoroallyl)hydrazine-1,2-dicarboxylate was 
confirmed with H1 NMR and mass spectroscopy. 
The Boc protecting group was removed by dissolving 1.00 g of di-tert-butyl 1-(2-
fluoroallyl)hydrazine-1,2-dicarboxylate in 8 mL of HCl (10 equiv) in dioxane and stirred 
at room temperature overnight.  The dioxane was removed by a rotovap and neutralized 
with NaOH to pH 7.0. The product 2-fluoroallyl-hydrazine was confirmed by H1 NMR 










Figure 3.1. Chemical synthesis of 2-fluoro-allylhydrazine 
 
Synthesis of 2-methylallyl-hydrazine 
10.00 g (0.043 mol) of N,N’-di-Boc-hydrazine, 11.87 g (2 equiv) of K2CO3, 6.03 
g (3.5 equiv) of NaOH and 1.47 g (0.1 equiv) of TBAHS were dissolved in 160 mL of 
toluene and 4.5 mL of 2-methyl-3-chloro-propene (1.05 equiv) dissolved in 15 mL of 
toluene was added dropwise at 20 mL/hr rate into the reaction mixture.  The reaction was 
conducted at room temperature and stirred overnight.  TLC analysis was used to monitor 
the formation of product.  Toluene was removed by a rotovap and 40 mL of water was 
added to the mixture and the organic phase was extracted 4 times with 80 mL of EtOAc, 
dried with Na2SO4 and separated by column chromatography.  The di-tert-butyl 1-(2-
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methylallyl)hydrazine-1,2-dicarboxylate was confirmed with H1 NMR and mass 
spectroscopy. 
The Boc protecting group was removed by dissolving 1.00 g of di-tert-butyl 1-(2-
methylallyl)hydrazine-1,2-dicarboxylate in 8 mL of HCl (10 equiv) in dioxane and stirred 
at room temperature overnight.  The dioxane was removed by a rotovap and neutralized 
with NaOH to pH 7.0. The product 2-methyl -hydrazine was confirmed by H1 NMR and 
mass spectroscopy. 
 
Synthesis of (Z)-dec-2-enylhydrazine 
Trans 1-bromo-2-decene was synthesized from 15 mL of trans-2-decen-1-ol 
dissolved in DCM, cooled in an ice bath and stirred for 10 min. 8.73 g (0.4 equiv) of PBr3 
was dissolved in 10 mL of DCM and added dropwise using a syringe pump and stirred 
for 6 hours.  The reaction was quenched with saturated NaHCO3 in aqueous solution and 
stirred for 30 minutes. The reaction mixture was extracted 4 times with 50 mL of DCM 
and purified on a column chromatography. 
5.30 g (0.043 mol) of N,N’-di-Boc-hydrazine, 6.25 g (2 equiv) of K2CO3, 3.20 g 
(3.5 equiv) of NaOH and 0.78 g (0.1 equiv) of TBAHS were dissolved in 80 mL of 
toluene and 5.00 g of trans-1-bromo-2-decene (1.05 equiv) dissolved in 5 mL of toluene 
was added dropwise at 20 mL/hr rate into the reaction mixture.  The reaction was 
conducted at room temperature and stirred overnight.  TLC analysis was used to monitor 
the formation of product.  Toluene was removed using a rotovap and 40 mL of water was 
added to the mixture and the organic phase was extracted 4 times with 80 mL of EtOAc, 
dried and separated by column chromatography.  The di-tert-butyl 1-(dec-2-en-1-
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yl)hydrazine-1,2-dicarboxylate was confirmed with H1 NMR and mass spectroscopy.  
The Boc protecting group was removed by dissolving 1.00 g of di-tert-butyl 1-(dec-2-en-
1-yl)hydrazine-1,2-dicarboxylate in 8 mL of HCl (10 equiv) in dioxane and stirred at 
room temperature overnight.  The dioxane was removed by a rotovap and neutralized 
with NaOH to pH 7.0.  The (Z)-dec-2-enylhydrazine was confirmed by H1 NMR and 
mass spectroscopy. 
 
3.2.2 Trinitrobenzene sulfonic acid (TNBS) assay 
Briefly, to 1 mL of allylhydrazine (25 µM) aqueous solution, were added 1 mL of 
4% NaHCO3 (pH 8.5). The mixture is incubated in a water bath at 42oC for 10 minutes.  
Next, 1 mL of 0.01% (341 µM) freshly made TNBS was added to the mixture and 
incubated at 42oC for 2 hours followed by the addition of 1 mL 10% SDS and 0.5 mL of 
1N HCl.  The absorbance was monitored at 335 nm, after appropriate blank corrections.  
The blank correction is prepared through the same procedure except that the concentrated 
HCl is added to the allylhydrazine solution prior to the addition of the TNBS reagent.  
To 5 mL of 25 µM allylhydrazine solution was added 50 µL of 100 mM Fe2+ and 
50 µL of 100 mM H2O2 solution.  This constitutes final concentration of 1 mM hydroxyl 
radicals.  The mixture is allowed to react for 1 hour, and the sample is subjected to TNBS 
assay as described earlier.  For blank correction, 1 mM ROS solution is prepared in DI 
water without addition of allylhydrazine.  Figure 3.2 shows how TNBS reacts with 
allylhydrazine and produced an absorbance at 335 nm. 
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Figure 3.2. Reaction of trinitrobenzene sulfonic acid (TNBS) with primary amine on 
allylhydrazine 
3.2.3 ABTS assay 
Briefly, stock solutions of ABTS (5 mM) and sodium persulfate (68.9 mM) in 
PBS (pH = 8.0) were prepared. Sodium persulfate stock solution (1 mL) was added to 
ABTS stock solution (99 mL).  The mixture was stored in the dark for 16 hours. This 
produced a solution of ABTS•+ which gave an absorbance of approximately 0.85 at 734 
nm. 10 mL stock solutions of neutralized allylhydrazine (pH = 7.0-7.5) were prepared, 
and several dilutions (10 µM, 100 µM, 1 mM, 10 mM) were prepared from the stock 
solution.  Filtered DI water was used for all dilution, and all measurements were done at 
room temperature (20oC).  The control is prepared by adding ABTS•+ to DI water only 
(containing no allylhydrazine), and no decrease in absorbance was observed.  Negative 
control is prepared by ABTS solution without sodium persulfate (hence no ABTS•+ 
radical).  The absorbance of ABTS solution plus allylhydrazine is nearly zero, indicating 
ABTS itself does not react with allylhydrazine. 
For kinetic measurement, 2 mL of allylhydrazine sample was added to a cuvette, 
and the absorbance was set to baseline.  Next 1 mL of ABTS•+ solution was rapidly 
added to the cuvette and the absorbance reading at 734 nm was taken every second for 5 
minutes.  The test was repeated four times for each dilution of allylhydrazine.  Data was 
exported to Excel and absorbance versus time graphs were generated.  Rate constants 
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were determined from the slope of the plots, and half-life was determined using the 
formula T1/2 = ln 2/k.  Figure 3.3 shows the structure of 2,2’-azinobis-3-
ethylbenzothiazoline-6-sulfonic acid radical cation (ABTS•+), and it has an absorbance 




Figure 3.3. Structure of 2,2’-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) 
 
3.3 Results 
3.3.1 Synthesis of allylhydrazine analogs 
The chemical synthesis was confirmed by proton H1 NMR and mass spectrometry.
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2-methyl-allylhydrazine MW+H = 87 
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2-fluoro-allylhydrazine MW+H = 91 
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(Z)-dec-2-enylhydrazine MW+H = 171 
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3.3.2 Oxidation of allylhydrazine with the hydroxyl radical  
We further verified that allylhydrazine can react with a physiological radical 
oxidant, the hydroxyl radical.  Allylhydrazine (25 µM) was incubated with an excess of 
hydroxyl radical (10 mM H2O2 + 10 mM Fe2+) for 1 hour and the depletion of 
allylhydrazine was determined using the trinitrobenzene sulfonic acid (TNBS) assay 
[110].  Figure 3.4 demonstrates that allylhydrazine is decomposed by radical oxidants 
into a product that has no reactivity with TNBS, presumably nitrogen and propene.  
TNBS assay of allylhydrazine (25 µM) generates an absorption peak at 335 nm (blue 
dash curve).  TNBS assay of allylhydrazine (25 µM) incubated with an excess of 
hydroxyl radicals (10 mM H2O2 + Fe2+) for 1 hour, does not generate an absorption peak 
at 335 nm, indicating the reaction of allylhydrazine (red curve).  Based on the results of 
the oxidation kinetics of allylhydrazine, we assumed that the other allylhydrazine analogs 
have similar kinetics and were subsequently investigated by acoustic characterization for 





















Figure 3.4.  Allylhydrazine reacts with the hydroxyl radical and is decomposed into a 
product that has no reactivity with TNBS 
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3.3.3 Oxidation kinetics of allylhydrazine with radical oxidants 
Figure 3.5 demonstrates that allylhydrazine reacts rapidly with radical oxidants. 
ABTS radical cation has a constant absorbance at 734 nm (dash line).  ABTS radical 
cation (230 µM) is reduced by excess allylhydrazine (6.6 mM) and loses its absorbance 
(red curve), with a half-life of 3.06 ± 0.0045 seconds and a pseudo first-order rate 





























3.4.1 Oxidation kinetics and implication for clinical applications 
Allylhydrazine is designed to nucleate gas bubbles in the presence of radical 
oxidants as shown in Figure 3.6.  In order to exceed the critical threshold needed for 
bubble nucleation, the allylhydrazine needs to oxidize rapidly in comparison to the rate of 
nitrogen diffusion.  We therefore investigated the oxidation kinetics of allylhydrazine 
 28
with the ABTS, a radical cation that is reduced by single electron oxidation of its 
substrates [111].  Figure 3.5 demonstrates that allylhydrazine reacts rapidly with radical 
oxidants with a pseudo first-order rate constant (k) of 0.23 ± 0.0003 s-1, which is 
consistent with literature values [44].  To compare this result under physiological 
conditions, we calculated the Thiele modulus, Φ, which is a dimensionless number that 
quantifies the ratio of reaction time to diffusion time, and a value greater than one 
indicates that the reaction rate is faster than the rate of diffusion [112].  The Thiele 
modulus is given by the equation:
D
kL2
=φ  where k is the first-order rate constant (s-1), 
L is the length (m) and D is the diffusion constant (cm2/s).  Assuming a 1 mm length of 
ROS-producing tissue, a rate constant k of 0.23 s-1 and a nitrogen diffusion constant of 
2.83 x 10-5 cm2/s, the Thiele modulus was calculated to be 9.  Therefore, the rate of 
nitrogen gas generated by allylhydrazine should be substantially faster than the rate of 
nitrogen gas diffusion [113], leading to accumulation of nitrogen gas in ROS-producing 




















3.4.2 Theoretical prediction for threshold of bubble nucleation 
The hydroxyl radical (.OH) was chosen because it is the most abundant radical 
oxidants in the body, and the major source of hydroxyl radicals in the body mainly 
derived from hydrogen peroxide (H2O2).  Studies suggest that physiological 
concentrations of hydrogen peroxide are in the nanomolar to micromolar range [114].  
Based on this information, we estimated the amount of nitrogen gas that can be generated 
from hydrogen peroxide:  
1 mol of gas = 22.4 L (under STP condition) 
Hydrogen peroxide level: 1 nM – 1 µM  
Assuming complete reaction of allylhydrazine with the hydroxyl radical (·OH), we 
determine that:  
Volume of a single bubble for various bubble sizes ( 3
3
4 rV π= ) 
 
Diameter of bubble 1um 10um 
5.24 x 10-19 5.24 x 10-13 Volume of single bubble (L) 
 
Number of bubbles present in 1mL solution for various hydroxyl radical concentrations 
and bubble sizes 
 
 Total volume of gas Number of bubbles 
(1um diameter) 
Number of bubbles 
(10um diameter) 
22.4 x 10-9 L 4.28 x 1010 4.28 x 104 1uM (·OH) 
22.4 x 10-12 L 4.28 x 107 42.8 1nM (·OH) 
 
The theoretical estimation of the amount of gas bubbles that can be generated 
serve as a reference for the detection limit of ultrasound.  The ultrasound detection of 
bubble nucleation will be investigated in Chapter 4. 
 30
CHAPTER 4 
ULTRASOUND DETECTION OF BUBBLE NUCLEATION 
4.1 Introduction 
Ultrasound is extremely sensitive to gas bubbles and can detect picoliter volume 
of gas bubbles due to their compressibility and the acoustic impedance mismatch between 
the gas and the liquid.  In this section, we investigated ultrasound detection of bubble 
nucleation generated from the oxidation of allylhydrazine by radical oxidants.  The first 
task was to examine if the oxidation of allylhydrazine by the hydroxyl radical could 
chemically generate gas bubbles, using a custom-built system that can simultaneously 
visualizes gas bubbles and measures their acoustic properties.  We showed that bubbles 
were observed optically and characterized the acoustic signals of the bubbles.  The 
second task was to investigate the acoustic response of bubble nucleation and to study the 
effects of ultrasound parameters on bubble nucleation.  We determined if bubble 
nucleation can be enhanced by ultrasound.  A key parameter determining the feasibility 
of using chemically-generated microbubbles for ROS imaging is the sensitivity of 
ultrasound to detect gas molecules above saturation in aqueous solutions.  Therefore, we 
will also investigate the limit of ultrasound, and determine the linear range of hydroxyl 
radical concentrations that can be detected by ultrasound.  Lastly, we will determine if 
bubble nucleation can be detected in vitro using a clinical ultrasound system and correlate 




4.2 Materials and Methods 
4.2.1 Optical observation and acoustic characterization of bubble nucleation 
A custom-built optical and acoustic measuring system was developed that can 
simultaneously visualize bubble nucleation and characterize its acoustic properties 
(Figure 4.1).  A solution containing 100 mM allylhydrazine and 1 mM hydroxyl radical 
(H2O2 + Fe2+) was pre-mixed in a syringe and injected into a 200 µm-diameter cellulose 
tube at a controlled flow rate.  The tube was also placed at the focal region of the 
transducer, and interrogated with 1.5 cycle pulses at a 2.25 MHz center frequency with an 
80 Hz pulse repetition frequency.  The tube was immersed in degassed water and the 
temperature is set to 37oC.  The cellulose tube was placed under a microscope stage 
linked to a digital camera for optical observation of bubble nucleation.  The acoustic data 




















Figure 4.1. Measuring system for simultaneous optical observation and acoustic 
characterization of bubble nucleation. 
 
4.2.2 Ultrasound characterization system 
A custom-built ultrasound testing system for in vitro characterization of 
allylhydrazine with the hydroxyl radical is shown in Figure 4.2.  Ultrasound was 
produced by a single element flat 2.25 MHz transducer with 0.5” element diameter, and a 
near field distance of 6 cm.  The signal is generated from a HP32250A arbitrary 
waveform generator and amplified through an ENI 320L RF power amplifier.  The 
ultrasound pulse was generated at 2.075 MHz, 400 mVpp, 10 ms pulse repetition period, 
20 cycle pulses and amplified 50 dB by the RF power amplifier.  The output signal was 
calibrated with the hydrophone to ensure operation in the linear region and the output 
pressure was 0.4 MPa.  The ultrasound signal was detected with a calibrated hydrophone.  
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The hydrophone is connected to a 20 dB gain preamplifier, and the hydrophone 
sensitivity is 6.2 Vpp/MPa with the preamplifier, and 0.12 Vpp/MPa without the 
preamplifier.  The received signal from the hydrophone is sent to a HP DSO5014A 
digital oscilloscope and the waveform is transferred to the computer through a GPIB 
cable. 
The contrast agent was placed in a container with acoustically transparent 
membrane.  The holder has a dimension of 59 mm (H) x 60 mm (W) x 10 mm (D), and 
able to hold 10 mL of solution.  For ultrasound testing, the transducer is place 6 cm in 
front of the holder at 45o angle, and the hydrophone is placed 3 cm behind the holder at 
45o angle.  Thus, the transducer is at a 90o angle with respect to the hydrophone.  This is 
done to minimize signal transmitted directly from the transducer.  The transducer, 
hydrophone and holder are positioned and fixed with clamps.  The water tank has a 
















Figure 4.2. Ultrasound measurement system for in vitro characterization of 
allylhydrazine with the hydroxyl radical 
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 A Matlab interface was used to control the center frequency, pulse amplitude, 
input signal offset, burst period, number of cycles, sampling rate, and number of FFT 
average (Figure 4.3).  The received echoes were processed with Fast Fourier Transform 




Figure 4.3. Matlab user interface for displaying data acquisition and setting ultrasound 
parameters. 
 
4.2.3 Optimization of ultrasound parameters 
Several different pulse sequences were used to investigate the effect of ultrasound 
parameters on bubble nucleation, including compression-first sinusoidal waves, pulse-
inversion waveform and rectified-diffusion corrected waveform.  Both focused and 
unfocused transducers with frequencies ranging from 1 MHz, 2.25 MHz, 5 MHz and 10 
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MHz were used.  The pulse repetition period was varied from 10 Hz to 100 Hz, and the 
burst period was set to 10 ms but the cycle length was varied from 1-80 cycles.  The 
acoustic pressure was varied from 100 kPa to 2 MPa, and was calibrated by the 
hydrophone prior to testing. Table 1 lists the parameters that were explored. 
 
Table 1. Ultrasound parameters that can affect bubble acoustic response 
Ultrasound parameter Setting 
Frequency 1MHz, 2MHz, 5MHz, 10MHz 
Peak negative pressure 100kPa, 400kPa, 1MPa, 2MPa 
Pulse sequence Sinusoidal, pulse inversion, rectified-diffusion corrected 
Pulse cycle length 1, 1.5, 10, 20, 40, 60, 80 cycles  
Pulse repetition period 10, 30, 50, 100Hz  
Transducer type Focused, unfocused 
 
For signal processing, the number of sample averaged by FFT was varied from 20 
samples to 50 samples.  The region of interest (ROI) was chosen to eliminate unwanted 
reflections from the wall of the container.  The ultrasound parameters were optimized by 
determining the parameters that result in the greatest change in ultrasound intensity (fold 
increase) within 10 minutes. 
 
4.2.4 In vitro ultrasound characterization of allylhydrazine with the hydroxyl radical 
In vitro acoustic characterization of bubble nucleation was done using non-
degassed deionized water at 37oC to mimic physiological condition in vivo.  However, 
the water tank is filled with degassed deionized (DI) water (except inside the contrast 
agent holder) to minimize background noise, and the water temperature is controlled by 
an immersible heater capable of controlling the temperature within +/- 1oC. 
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The water bath is replaced with fresh degassed DI water each day prior to 
ultrasound testing.  Ten milliliters of filtered non-degassed DI water was added into the 
holder through a syringe via a 16 gauge needle.  The signal was measured and recorded 
as the baseline.  Any abnormality would be noticed here, such as any free gas bubble 
already present in the holder.  Free gas bubble was removed by repeated sonication in 
sonication bath, until the baseline returns to the noise level.  Next, 1 mL of DI water was 
taken out of the solution through the syringe and 1 mL of (1 M) allylhydrazine solution 
was added and allowed to mix by diffusion.  Then 2 mL of contrast agent solution is 
taken out from the holder, and 1 mL of H2O2 stock solution and 1 mL of (10 mM) Fe2+ 
stock solution was added.  Immediately after the injection of H2O2 and Fe2+, the signal 
was measured and recorded at time points: 0, 1, 3, 5, 7, 10, 15 and 20 minutes.  The test 
was repeated at various H2O2 concentrations from 1 µM to 1 mM, with fixed 
concentration of Fe2+ at 1 mM.  DI water was used instead of H2O2 as the control for no 
radical oxidants.  The test was repeated to obtain 4 data sets for each H2O2 concentration, 
and the result of ultrasound intensity versus H2O2 concentration was plotted with standard 
error for each time point. 
 
4.2.5 In vitro characterization with clinical ultrasound system 
A Siemens Antares clinical ultrasound machine was used to image bubble 
nucleation inside the holder.  Allylhydrazine was placed inside the custom-made acoustic 
holder and various concentrations of hydroxyl radicals were used: 1 µM, 10 µM, 100 
µM.  Deionized water was used as the control for no radical oxidants. 
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Figure 4.4 shows the in vitro system for imaging bubble nucleation with the 
Siemens clinical ultrasound probe.  The ultrasound probed is placed in front of the 
acoustic opening in the water bath container, and the acoustic gel is applied at the 
interface between the ultrasound probe and the acoustic window.  Hot water running 
through a copper heat coil was used to maintain the water temperature at 37oC.  An 
acoustic absorber was placed behind the contrast agent holder to minimize standing wave 
and reflection.  Briefly, 10 mL of 100 mM allylhydrazine solution was prepared inside 
the holder.  Then, 2 mL of solution was taken out with a syringe and replaced with 1 mL 
of Fe2+ (1 mM) and 1 mL of H2O2 at various concentrations into the holder.  The video 
intensity was recorded before and after the addition of Fe2+ and H2O2 solution at time 
points from 0, 1, 3, 5, 7, 10, 12 to 15 minutes. 
 
 
Figure 4.4. In vitro characterization system of bubble nucleation using clinical 








Figure 4.4. (B) Top view 
 
The clinical ultrasound setting was 5.71 MHz transmitted frequency, MI = 1.5 
(3.58 MPa peak negative pressure), 6 cm depth, and 50 dB receiving gain.  Figure 4.5 
illustrates the video intensity of the holder recorded on the screen.  The probe is on the 
top, and the middle two lines are the boundary of the holder membrane.  The region of 








Figure 4.5.  Representative ultrasound image showing the region of interest 
 
The experiments were repeated in triplicate at each concentrations of the hydroxyl 
radical and image analysis was performed using the ImageJ software to quantify the 
change in video intensity.  The background signal was subtracted from the image as 
illustrated in Figure 4.6.  The result of change in mean video intensity versus time for 
each H2O2 concentration was plotted. 
 
 
Figure 4.6. Background subtraction of ultrasound video images 
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4.3 Results 
4.3.1 Optical confirmation of bubble nucleation 
We examined if the oxidation of allylhydrazine by the hydroxyl radical could 
chemically generate gas bubbles, using a custom-built system that simultaneously 
visualizes gas bubbles and measures their acoustic properties.  For these experiments, a 
100 mM allylhydrazine solution containing a 1 mM hydroxyl radical concentration was 
injected into a 200 µm-diameter cellulose tube and then imaged.  Figure 4.7 
demonstrates that allylhydrazine can nucleate bubbles in the presence of hydroxyl 
radicals.  Fig. 4.7 frame 1 shows an image of the cellulose tube containing deionized 
water, and has no evidence of bubble formation.  In contrast, after injecting 
allylhydrazine and Fenton’s reagent into the cellulose tube, bubbles became optically 
visible.  For example, Figures 4.7 frames 2-4 show a bubble flowing through the 
cellulose tube generated from the oxidation of allylhydrazine with the hydroxyl radical.  
Chemically generated gas bubbles were also observed at lower hydroxyl radical 
concentrations (100 μM), albeit at a slower rate. 
 
1 2 3 4
100um
 
Figure 4.7.  Video images of the cellulose tube showing that allylhydrazine can nucleate 
gas bubbles in the presence of the hydroxyl radical.  There was no evidence of bubble 
formation inside the cellulose tube prior to the hydroxyl radical injection (1).  After the 
injection, gas bubbles became visible inside the cellulose tube, and video images (2-4) 
demonstrate a single gas bubble flowing through the cellulose tube.   
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We further investigated if the gas bubbles generated from the oxidation of 
allylhydrazine by the hydroxyl radical could be detected acoustically.  Figure 4.8 
demonstrates that strong acoustic echoes are generated from a microbubble identified by 
optical observation (55-58 µs).  For example, the microbubble identified in Figure 4.7 
frames 2-4 displayed a 20 fold increase in acoustic signal intensity in comparison to 
adjacent fluid at 2.25 MHz frequency using a 0.5” diameter transducer at a distance of 5.1 
cm.  These results suggest that allylhydrazine has the potential for imaging ROS. 
 
 
























Figure 4.8. The microbubble identified by optical observation inside the cellulose 
generated a strong acoustic echo (55 – 58 µs).  The microbubble displayed a 20 fold 
increase in acoustic signal intensity compared to adjacent fluid. 
 
4.3.2 Optimization of ultrasound parameters 
We found that the focused transducer produced more energy but was limited to a 
smaller excitation region.  Higher frequency produced better spatial resolution, but 
suffered from shorter penetration depth and weaker signal.  The output of the transducer 
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became saturated above 400 kPa peak negative pressure.  Pulse inversion and rectified-
diffusion enhanced waveform did not generate significant difference compared with 
sinusoidal waveform.  Using pulse cycle length greater than 80 cycle pulses resulted in 
multiple reflections and the returned signals became convoluted.  However, using cycle 
length shorter than 10 cycles resulted in a very weak returned signal.  A 100 Hz pulse 
repetition frequency was sufficient for the returned signal to attenuate completely before 
the next pulse and reducing the FFT average from 50 samples to 20 samples produced 
similar results.  The optimal ultrasound parameters for a 2.25 MHz unfocused transducer 
are 400 kPa acoustic pressure, sinusoidal waveform, 20 cycle pulse length, and 100Hz 
pulse repetition period. 
 
4.3.3 Acoustic response of allylhydrazine with the hydroxyl radical 
The acoustic responses of allylhydrazine before and after the addition of the 
hydroxyl radical are shown in Figures 4.9 and 4.10.  Figure 4.9a shows the received 
ultrasound echoes in the time domain, and the region of interest (ROI) between 40 – 80 
µs corresponded to the acoustic signal generated from the contrast agent holder 
containing 100 mM allylhydrazine.  Figure 4.9b shows the processed ultrasound signals 
in the frequency domain after taking the Fast Fourier Transform of 20 individual 
timeframes in the ROI sampling at 100 MHz, and then taking the average of 20 frequency 
responses.  The peak amplitude at 2.08 MHz before the addition of the hydroxyl radical 
was recorded as the baseline intensity.  Figure 4.10a shows that after the hydroxyl 
radical (100 µM) was added to the allylhydrazine inside the contrast agent holder, there 
was significant increase in the ultrasound echoes after 10 minutes.  Figure 10b shows the 
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processed ultrasound signal in the frequency domain after taking the Fast Fourier 
Transform of 20 individual timeframes in the ROI sampling at 100 MHz, and then taking 
the average of 20 frequency responses.  The peak amplitude at 2.08 MHz increased by 22 
dB, and the presence of 2nd and 3rd harmonics indicate strong acoustic response generated 
from the reaction of allylhydrazine with radical oxidants. 
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Figure 4.9. Acoustic characterization of allylhydrazine before the addition of the 
hydroxyl radical. A) Acoustic response of allylhydrazine in the time domain. B) Acoustic 
response of allylhydrazine in the frequency domain after Fast Fourier transform in the 
region of interest (40 – 80 μs). 
 








































Figure 4.10. Acoustic characterization of allylhydrazine after the addition of the 
hydroxyl radical (100 µM).  A) Acoustic response of allylhydrazine in the time domain. 
B) Acoustic response of allylhydrazine in the frequency domain after Fast Fourier 




The acoustic response generated from allylhydrazine and the hydroxyl radical 
(Fe2+ + H2O2) over time is shown in Figure 4.11.  The fold increase in ultrasound 
intensity was calculated by dividing the acoustic intensity with radical oxidants (I) by the 
baseline intensity before the addition of radical oxidants (Io).  The ultrasound echo 
reached peak intensity within 10 minutes for 10 µM, 50 µM and 100 µM concentrations 
of hydroxyl radical.  The vertical bars represent standard error of the mean, with n = 4 for 
































Figure 4.11. Allylhydrazine can react with hydroxyl radicals to generate bubbles and 
reach its peak acoustic intensity within a 10 minute period. 
 
Physiologic radical oxidants concentrations are speculated to occur in the 
nanomolar to micromolar range [114], and we investigated if allylhydrazine could detect 
radical oxidants at this low concentration.  Excess allylhydrazine (100 mM) was mixed 
with various concentrations of the hydroxyl radical (10 µM - 1 mM) and the ultrasound 
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echo response was transmitted and received at 2.25 MHz (Mechanical Index = 0.28).  
Figure 4.12 demonstrates that allylhydrazine can detect a 10 µM hydroxyl radical 
concentration, and displays a linear correlation between ultrasound intensity and 
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Figure 4.12.  Allylhydrazine can detect micromolar concentrations of ROS and showing 
a linear correlation between ultrasound intensity and the hydroxyl radical concentration 
within the concentration range of 10 µM - 1 mM (R2 = 0.98). 
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The effects of various ultrasound parameters and the acoustic response of 












100mM 100uM 2.07 0.4 20 sinusoidal 50 11.3
100mM 50uM 2.07 0.4 20 sinusoidal 50 5.4
100mM 25uM 2.07 0.4 20 sinusoidal 50 4.4
100mM 100uM 2.07 0.4 40 sinusoidal 50 14.5
100mM 20uM 2.07 0.4 40 sinusoidal 50 4.6
100mM 10uM 2.07 0.4 40 sinusoidal 50 1.3
100mM 10uM 2.07 0.4 60 sinusoidal 50 3.6
100mM 5uM 2.07 0.4 60 sinusoidal 50 1.0
100mM 0uM 2.07 0.4 20 sinusoidal 20 1.2
100mM 10uM 2.07 0.4 60 Pulse inversion 20 1.4
100mM 5uM 2.07 0.4 60 Pulse inversion 20 1.9
100mM 5uM 2.07 0.4 60 Pulse inversion 20 1.7
Table 2. Summary of ultrasound parameters and acoustic response of 




The acoustic responses of allylhydrazine analogs with various concentrations of 
the hydroxyl radical were investigated, and Table 3 provides a summary of the acoustic 
response of 2-fluoro-allylhydrazine, 2-methyl-allylhydrazine, and (Z)-dec-2-
enylhydrazine.  The addition of methyl or fluorine group on the 2’ carbon position did not 
enhance the acoustic response of bubble nucleation significantly, and the results were 












250mM 50uM 2.07 0.4 20 sinusoidal 50 1.2
100mM 100uM 2.07 0.4 20 sinusoidal 50 1.5
95mM 100uM 2.07 0.4 20 sinusoidal 50 1.4
25mM 100uM 2.07 0.4 20 sinusoidal 50 3
5mM 50mM 2.07 0.4 20 sinusoidal 50 6.1
5mM 1mM 2.07 0.4 20 sinusoidal 50 2.5
5mM 0.5mM 2.07 0.4 20 sinusoidal 50 2.3
5mM 50uM 2.07 0.4 20 sinusoidal 50 1











100mM 100uM 2.07 0.4 20 sinusoidal 50 3.2
62mM 100uM 2.07 0.4 20 sinusoidal 50 3
50mM 100uM 5MHz 0.4 20 sinusoidal 50 1.6











250mM 200uM 2.07 0.4 20 sinusoidal 50 2.1
200mM 100uM 2.07 0.4 20 sinusoidal 50 1.2
50mM 1.5mM 2.07 0.4 20 sinusoidal 50 26.9
40mM 1mM 2.07 0.4 20 sinusoidal 50 3.5
25mM 3mM 2.07 0.4 20 sinusoidal 50 15.5
25mM 1mM 2.07 0.4 20 sinusoidal 50 2.2
20mM 5mM 2.07 0.4 20 sinusoidal 50 18.9
10mM 10mM 2.07 0.4 20 sinusoidal 50 11.05
5mM 10mM 2.07 0.4 20 sinusoidal 50 1
Table 3. Summary of acoustic response of allylhydrazine analogs with various 
concentrations of the hydroxyl radical
 
 48
4.3.4 In vitro characterization of bubble nucleation with clinical ultrasound system 
Representative results of detecting bubble nucleation with a clinical ultrasound 
system at various concentrations of the hydroxyl radical are shown in Figure 4.13.  The 
background signals have been subtracted from the ultrasound images and shown over 10 
minutes.  Over time, bright spots began to accumulate on the holder membrane that was 
further away from the ultrasound probe.  Interestingly, the location of the bubbles aligned 
directly with the area where the ultrasound probe was focused.  This indicated that 
ultrasound enhanced bubble nucleation and regions outside the focal region of the 
ultrasound probe had less bubbles.  At higher concentrations of hydroxyl radicals, 
stronger video intensity and more bubble formation were observed.  For example, a 10 
µM hydroxyl radical concentration produced stronger video intensity than a 1 µM 













Figure 4.13. Representative ultrasound images of bubble detection with a clinical 




These video images showed that bubble nucleation can be detected with a clinical 
ultrasound probe.  To quantify the change in video intensity from bubble nucleation, the 
mean video intensity in the region of interest was measured over time for each hydroxyl 
radical concentration.  Figure 4.14 shows that higher hydroxyl radical concentrations 
correlated with stronger video intensity. 
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Figure 4.14.  Bubble generation from the reaction of allylhydrazine with the hydroxyl 
radical can be detected in vitro by a clinical ultrasound system.  Higher hydroxyl radical 
concentration results in greater change in mean video intensity within 15 minutes.   
 
We also investigated if ultrasound can enhance bubble formation.  The 
experiments were measured at 5.71 MHz using mechanical index (MI) = 1.5 (3.58 MPa) 
and MI = 0.6 (1.43 MPa).  Figure 4.15 shows that more bubbles accumulated inside the 
holder at higher MI = 1.5 compared to lower MI = 0.6.  This indicates that stronger 
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Figure 4.15.  Representative ultrasound images showing that more bubbles are generated 
inside the holder at higher mechanical index (MI) 
 
The quantitative analysis of the effect of mechanical index on video intensity is 
plotted in Figure 4.16.  For a MI of 0.6 and a 100 µM hydroxyl radical concentration, the 
mean video intensity remained constant.  However, for a MI of 1.5, the mean video 
intensity increased by more than 40%, which suggested that ultrasound power can 
enhance bubble nucleation.  The error bar represent standard error (n = 3). 
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Figure 4.16.  Stronger ultrasound power (higher MI) resulted in larger change in video 
intensity, suggesting enhancement of bubble nucleation 
 
4.4 Discussion 
4.4.1 Optical observation of bubble nucleation  
We were able to observe and record optically large bubbles (>50 µm) using the 
custom-built ultrasound testing system.  Although smaller bubbles were also observed, 
they were not captured due to the limitation of the testing system.  Smaller bubbles were 
more unstable and collapsed quickly once they are formed; however, larger bubbles 
coalesced from smaller bubbles were more stable and easier to capture optically.  Using 
lower hydroxyl radical concentration resulted in fewer bubbles observed.  The acoustic 
characterization of the microbubble identified by optical observation inside the cellulose 
tube demonstrated bubble-specific acoustic signal.  Fast Fourier transform of the region 
of interest showed that the amplitude at 2.25 MHz (the interrogation frequency) increased 
by 15 dB (5 fold) when the bubble was present.  These studies confirmed that the 
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oxidation of allylhydrazine by radical oxidants can nucleate bubbles and can be detected 
with ultrasound. 
 
4.4.2 Classical nucleation theory and observed results 
Classical bubble nucleation theory predicted that homogenous bubble nucleation 
occurs at exceedingly high concentrations above gas supersaturation [49-50].  However, 
physiological concentrations of ROS are believed to occur in the nanomolar to 
micromolar range, and to detect this level of radical oxidants can be challenging because 
this concentration represents a small change above gas saturation.  The in vitro acoustic 
characterization showed that ultrasound was able to detect a 10 µM radical oxidant 
concentration (Fig. 4.12).  This concentration represents a small increase above the 
nitrogen gas saturation concentration, which is 450 µM, and it is unclear if full bubble 
nucleation is occurring at this low level of supersaturation.  Furthermore, the production 
of hydroxyl radical from Fenton’s reagent is not a 100% yield process [115], which 
means that the actual concentrations of hydroxyl radical could be much lower. 
To address the issue of bubble nucleation, many have shown that in the presence 
of pre-existing bubble nuclei, such as on the surfaces of the container or in the bulk 
solution, bubble nucleation occurs at much lower concentrations than theoretical 
prediction [49, 51].  These bubble nuclei or ‘embryos’ enhance bubble nucleation by 
lowering the energy barrier required to reach the critical nuclei radius [50, 53].  It has 
also been reported that bubble nucleation generated from chemical reactions occurs at 
much lower concentrations than theoretical prediction [52].  These evidences show that 
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although classical bubble nucleation theory is useful in predicting homogenous bubble 
nucleation, it has limited applications in heterogeneous conditions [51]. 
Furthermore, from the acoustic perspective, the pressure required for bubble 
nucleation in homogeneous water has been widely reported to exceed 10 MPa [116-117].  
With the inclusion of physiologically-relevant nuclei, gas saturation and interfacial 
tension, the cavitation threshold decreases to hundreds of kilopascals at 0.75 or 1 MHz 
[118-119].  Ultrasound is extremely sensitive to the presence of small gas bubbles due to 
the large change in density and compressibility of such bubbles as compared with saline 
or plasma, and ultrasound detection of individual micron-sized gas bubble on the order of 
pL (10-12 L) volume has been demonstrated [55-57].  Here, nitrogen gas were generated 
in the presence of radical oxidants and increase the gas saturation beyond the saturation 
limit, creating a state in which small perturbations are expected to result in bubble 
nucleation.  We hypothesize that the perturbations induced by ultrasound could enhance 
the nucleation rate under such conditions, and at low radical oxidant concentrations, 
ultrasound detected mixed states of gases and liquids [120].  Bubble nucleation can also 
be enhanced by ultrasound via rectified diffusion or inertial cavitation [121]. 
 
4.4.3 Effect of ultrasound parameters on bubble nucleation and rectified diffusion  
The purpose of studying the effect of ultrasound parameters was to determine if 
bubble nucleation could be enhanced by ultrasound.  It is known that bubble behavior can 
be affected by ultrasound such as rectified diffusion and inertial cavitation.  In rectified 
diffusion, bubbles can grow in size after the acoustic pressure exceeds above a certain 
threshold.  On the other hand, if the acoustic pressure is too high, the bubbles can expand 
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and collapse violently, resulting in cavitation.  Therefore, various ultrasound parameters 
were investigated, including different frequencies (1-10 MHz), pulse sequences, pressure 
(100 kPa - 2 MPa), pulse repetition period (10-100 Hz), frequency modulation (chirp), 
and power modulation (strong pulse followed by weak intensity pulse).  The goal was to 
optimize the ultrasound setting to detect bubble nucleation generated from the oxidation 
of allylhydrazine by radical oxidants. 
To understand the interaction between ultrasound beam and bubble formation, we 
received help from our collaborator, Dr. Shengpin Qin in Dr. Catherine Ferrara’s lab.  He 
provided some theoretical explanations to our observation.  In essence, the change in 
bubble radius can be modeled by the gas diffusion equation for acoustically-driven 
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Where Ro is the initial bubble radius, D is the gas diffusion coefficient, T is the 
temperature, σ is the surface tension coefficient, P is the internal pressure, Rg is the 
universal gas constant, Ci is the concentration of gas dissolved in the liquid far from the 
bubble, Co is the saturation concentration of gas in the liquid.  A and B are the time-
dependent radial expansions of bubble radius and the ratio of A/B is governed by the 



















































The last two terms in the Eller-Flynn equation indicate that the rate of change of 
radius is positive if Ci/Csn > A/B, meaning that bubble will grow.  On the other hand, if 
the rate of change of radius is negative, bubble will dissolute.  The condition when Ci/Csn 
- A/B = 0 is the threshold for rectified diffusion.  
The threshold for rectified diffusion was modeled in Figure 4.17, which 
displayed the threshold for rectified diffusion with sinusoidal oscillation at 1 MHz 
frequency.  The region above the curve shows the condition for rectified diffusion, and 
the region below the curve shows where bubble dissolution occurs.  For bubbles smaller 
than 1um, the acoustic pressure needed to generate rectified diffusion is very high, and 
bubbles can also fragment.  However, the pressure required to generate rectified diffusion 
for bubbles larger than 1um is significantly lower.  Furthermore, larger bubbles are more 
stable because of lower surface tension.  This explains why bubbles smaller than 10 μm 






































Figure 4.17.  Threshold for rectified diffusion at 1 MHz sinusoidal oscillation frequency.  
The region above the curve is the condition for rectified diffusion, and the region below 
the curve is the condition for bubble dissolution. 
 
The threshold for rectified diffusion at 2.25 MHz and 5 MHz sinusoidal 
frequencies were also modeled and displayed in Figures 4.18 and 4.19.  The results were 
similar to the threshold at 1 MHz, and this explained why different frequencies and pulse 
sequences did not have significant contribution to bubble nucleation.  Other factors in the 
Eller-Flynn equation can also contribute to bubble dissolution, such as the degree of gas 




































Figure 4.18.  Threshold for rectified diffusion at 2.25 MHz sinusoidal oscillation 
frequency.  The region above the curve is the condition for rectified diffusion, and the 




































Figure 4.19.  Threshold for rectified diffusion at 5 MHz sinusoidal oscillation frequency.  
The region above the curve is the condition for rectified diffusion, and the region below 
the curve is the condition for bubble dissolution. 
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CHAPTER 5  
LIPOSOMAL ENCAPSULATION AND STABILIZATION OF ROS-
INDUCED MICROBUBBLE 
5.1 Introduction 
In order to reduce bubble dissolution and increase bubble stability, many have 
found that encapsulating gas microbubbles inside an amphiphilic biocompatible 
phospholipid shell can effectively lower the interfacial tension, adding rigidity and 
reducing gas escape [123-124].  Microbubbles encapsulated within liposomes smoothly 
expand and contract, and instantaneously self-assemble to repair membrane structure 
even during the ultrasound pulse.  Furthermore, liposomes have been used in many 
applications of drug delivery, and their in vivo characteristics have been studied 
extensively, including biodistribution, biocompatibility, degradation and excretion 
pathways. 
To test the hypothesis that liposome encapsulation of microbubbles can improve 
bubble stability and enhance in vivo efficacy, we adapted the liposome composition from 
a FDA-approved commercial contrast agent, Definity [86].  Definity is composed of 10 
mol % 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), 10 mol % 1,2-
dipalmitoyl-sn-glycero-3-phosphatidic acid (DPPA), and 80 mol % 1,2-Dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC).  The main phospholipid in this formulation is a 
neutral 16-carbon chain, and the charged DPPA phospholipid is designed to enhance 
bubble dispersion by adding a repulsive columbic force around the gas bubbles.  In 
addition, liposomes with poly-ethyl-glycol (PEG) chains can prevent bubble coalescence 
and provide longer circulation time for in vivo applications.  Another advantage of 
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encapsulating allylhydrazine inside the liposomes is to increase the local concentration of 
allylhydrazine and the probability for bubble nucleation.   
In order to generate the hydroxyl radical (•OH) from hydrogen peroxide (H2O2), 
iron is needed.  However, sufficient amount of iron may not be present in areas with high 
production of ROS.  One strategy is to incorporate iron complexed with hydrophobic 
porphyrin in the lipid bilayer.  This will increase the sensitivity of allylhydrazine toward 
hydrogen peroxide. 
We therefore investigated several liposomes formulation strategies, including the 
concentration of individual phospholipid, the phospholipid chain length, the amount of 
charged phospholipid, incorporating PEG chains and iron-porphyrin.  The sizes of the 
liposomes and their encapsulation efficiency for allylhydrazine were also studied, and the 
final composition was optimized for in vivo applications.  The acoustic response of 
allylhydrazine encapsulated within liposomes (APLs) reacting with the hydroxyl radical 
was characterized, and we found that APLs displayed stronger ultrasound intensity than 
free allylhydrazine.  Finally, biodistribution of liposomes loaded with a fluorescent dye 
was investigated in vivo, and the liver was identified as an appropriate target for in vivo 
imaging. 
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5.2 Materials and Methods 
5.2.1 Liposome composition and formulation 
Various types of phospholipids were used, and Table 4 provides a list of all the 
phospholipids used in this work and their abbreviation.  All phospholipids were 
purchased from Genzym (Pittsburgh, PA). 
 
Table 4. Phospholipid types and abbreviation 
Abbreviation Lipid Name 
DPPE 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine 
DSPE 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine 
DPPA 1,2-Dipalmitoyl-sn-glycero-3-phosphatidic acid 




DPPE-PEG5k N-(Carbonyl-methoxypolyethyleneglycol 5000)-1,2 dipalmitoyl-
sn-glycero-3- phosphoethanolamine 
DPPE-PEG2k N-(Carbonyl-methoxypolyethyleneglycol 2000)-1,2 dipalmitoyl-
sn-glycero-3- phosphoethanolamine 
DSPE-PEK2k N-(Carbonyl-methoxypolyethyleneglycol 2000)-1,2 distearoyl-sn-
glycero-3- phosphoethanolamine 
 
The standard liposome formulation is composed of 80 mol % DPPC, 10 mol % 
DPPE and 10 mol % DPPA.  For PEGlyated lipid formulation, DPPE is replaced with 
DPPE-PEG5000.  Briefly, 100 mg lipids were dissolved in chloroform in a 250 mL round 
bottom flask, and the solvent is evaporated on a rotovap to form a thin film on the wall of 
the flask, followed by drying over high vacuum for at least 8 hours.  The lipid film is 
reconstituted with allylhydrazine solution, and heated to 5oC above the phospholipids 
main phase transition temperature (Tm = 41oC for DPPC, 55oC for DSPC), followed by 
rapid quenching to 0oC in an ice-water bath.  The heat/thaw cycle is repeated for at least 3 
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times over a period of 1 hour, until a clear/semi-transparent solution is observed.  The 
solution is then sonicated in a sonicator bath for 1-2 minutes, and subjected to ultrasound 
testing immediately.  Table 5 lists the composition and the final lipid concentrations 
examined in this work. 
 
Table 5. Liposomes compositions  
Composition Lipid concentration
10% DPPA, 10% DPPE, 80%DPPC 1mg/mL
10% DPPA, 10% DPPE, 80%DPPC 0.5mg/mL
10% DPPA, 10% DPPE, 80%DPPC 0.4mg/mL
10% DPPA, 80% DPPC, 10% DPPE-PEG5K 1mg/mL
80% DSPC, 10% DPPA, 10% DPPE-PEG5k  + porphyrin (1mM) 1mg/mL
90% DAPC, 10% DSPE-PEG2k 1mg/mL
10% DSPE, 90% DSPC 0.5mg/mL  
 
Liposome Dialysis 
The liposomes were injected into 2000 MWCO Dialysis Cassettes (Pierce Slide-
A-Lyzer, Thermo Fisher) and dialyzed in 3 L of deionized water for 6-8 hours.  The 
deionized water was replaced with fresh deionized water every hour. 
 
5.2.2 Liposome characterization 
The sizes of liposome were characterized by a Brookhaven Particle Size Analyzer 
instrument based on DLS (dynamic light scattering) measurement. 
The encapsulation efficiency of allylhydrazine inside liposomes was 
characterized.  Two stock solutions of liposomes were prepared: one before dialysis and 
the other after dialysis.  The liposomes in both stock solutions were lysed with 2 % 
Triton.  The undialyzed liposomes were incubated with the TNBS assay to determine the 
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concentrations of amine present in the solution and the measured absorbance was taken 
as 100 % encapsulation efficiency.  The dialyzed liposomes were also incubated with the 
TNBS assay to determine the concentration of amine present in the solution.  The 
encapsulation efficiency was calculated by dividing the absorbance of undialyzed 
liposomes over the absorbance of dialyzed liposomes.  Appropriate blank controls were 
used to correct for background absorbance. 
 
5.2.3 In vitro acoustic characterization of allylhydrazine encapsulated in liposomes  
The in vitro acoustic characterization of APLs was performed using the same 
protocols for free allylhydrazine (section 4.2.4).  Briefly, the water tank is filled with 
fresh degassed DI water at 37oC and the water temperature is controlled by an immersible 
heater capable of controlling the temperature within +/- 1oC.  The contrast agent holder 
was filled with 10mL filtered non-degassed DI water, and the background acoustic signal 
was measured and recorded.  Next, 1 mL of DI water was taken out of the holder through 
a 16-gauge needle syringe and 1 mL APL solution was added into the holder and allowed 
mixing by diffusion for 5 minutes.  Then 2 mL solution is taken out of the holder, and 1 
mL of H2O2 stock solution and 1 mL of Fe2+ stock solution (10 mM) were added.  
Immediately after the injection of H2O2 and Fe2+, the acoustic signal was measured and 
recorded at time points: 0, 1, 3, 5, 7, 10, 15 and 20 minutes.  The test was repeated at 
various H2O2 concentrations from 1 μM to 1 mM, with fixed concentration of Fe2+ (1 
mM).  DI water was used instead of H2O2 as the control for no radical oxidants. 
Two independent controls were used to verify bubble nucleation from the 
oxidation of allylhydrazine with radical oxidants.  To investigate if liposomes alone could 
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be echogenic and generate acoustic signal, empty liposomes (without allylhydrazine) 
were tested at various concentrations of H2O2 and Fe2+ (1 mM).  To investigate if 
allylhydrazine is specific toward hydroxyl radical and not reacting with hydrogen 
peroxide alone, various H2O2 concentrations (10 µM, 100 µM, 1 mM) were added to the 
solution containing APLs (100 mM) without Fe2+. 
 
5.2.4 In vivo biodistribution of liposomes loaded with fluorescent marker 
To determine the biodistribution of liposomes and whether they can reach the 
liver within 10 minutes, the liposomes were loaded with IR-786 dye and injected 
intravenously into a mouse for near-IR fluorescence imaging.  The mouse was sacrificed 
10 minutes after liposomes injection, and the chest was opened and imaged with an 
Olympus OV100 fluorescence imaging system.  
To determine if the dye-loaded liposomes only remained in the circulation or also 
accumulated in the tissue in the previous experiment, the vena cava was ligated and the 
heart was perfused with 5 mL of saline until the liver turned from reddish pink to pale 
white.  As a control to remove auto-fluorescence, the same experiment was performed on 
another mouse injected with saline instead of liposomes loaded with fluorescent dye.  The 
heart, liver, lung and kidney from both mice were harvested and placed in a Petri dish 
side by side for comparison.  
In another study to determine the biodistribution of liposomes more accurately, 
one group of mice (n = 3) were injected intravenously with liposomes loaded with 
Rhodamine B, and another group of mice (n = 3) were injected with empty liposome.  10 
minutes after liposome injection, the mice were sacrificed and the liver, lung, heart, 
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kidney and blood were harvested.  The blood was drawn from the right ventricle of the 
heart directly and mixed with heparin to prevent blood coagulation.  The organs were 
weighed and added with 1 mL of RIPA buffer, homogenized, and centrifuged for 2.5 min 
at 9000 rpm.  The supernatant were aliquoted unto a microplate, and the fluorescence was 
measured using a filter setting for Rhodamin B (Ex: 540/Em: 625).  The fluorescence was 




5.3.1 Physical characterization of liposomes 
The liposomes sizes were characterized by DLS and were in the range between 
30-100nm.  The figures below displayed the results from various liposome formulations. 
 
Allylhydrazine encapsulated within liposomes versus empty liposome 
Liposomes with 1 M allylhydrazine: 80 % DSPC, 10 % DPPA, 10 % DPPE-PEG5K (10 




Empty liposomes: 80 % DSPC, 10 % DPPA, 10 % DPPE-PEG5K (10 mg/mL), mean 
diameter = 55 nm 
 
 
Liposomes loaded with IR-786 dye 
Liposomes loaded with IR-786: 80 % DSPC, 10 % DPPA, 10 % DPPE-PEG5K (10 




Liposomes before and after dialysis 
Liposomes before dialysis: 80 % DSPC, 10 % DPPA, 10 % DPPE-PEG5K (10 mg/mL) 




Liposomes after dialysis: 80 % DSPC, 10 % DPPA, 10 % DPPE-PEG5K (10 mg/mL) 




Liposomes at lower lipid concentration 
80 % DSPC, 10 % DPPA, 10 % DPPE-PEG5K (2 mg/mL) and 1 M allylhydrazine, mean 
diameter = 97 nm 
 
 
Liposomes with Fe2+ and H2O2 
Liposomes without Fe2+: 80 % DPPC, 10 % DPPA, 10 % DPPE-PEG5K (10 mg/mL) and 




Liposomes with 1 mM Fe2+: 80 % DPPC, 10 % DPPA, 10 % DPPE-PEG5K (10 mg/mL) 




Liposomes with 1 mM Fe2+ and 10 μM H2O2: 80 % DPPC, 10 % DPPA, 10 % DPPE-





The encapsulation efficiency of liposomes was determined by the TNBS assay.  
Both dialyzed and undialyzed liposomes were lysed with 3% Triton to release the free 
allylhydrazine, which can react with the TNBS assay and produce an absorbance at 335 
nm.  The encapsulation efficiency of liposomes composed of 80% DSPC, 10% DPPA, 
10% DPPE-PEG5000, and 1 M allylhydrazine typically ranged from 50% - 65%.  The 
encapsulation efficiency was calculated from the absorbance of dialyzed liposomes 
divided by the absorbance of undialyzed liposomes at 335 nm absorbance wavelength.  
Figure 5.1 shows a representative plot of the TNBS assay that was used to determine the 
encapsulation efficiency. 
 
























5.3.2 In vitro acoustic response of allylhydrazine encapsulated within liposomes 
Overall, allylhydrazine encapsulated within liposomes are more effective at 
detecting the hydroxyl radical than free allylhydrazine.  PEGylated liposomes exhibited 
stronger acoustic response than non-PEGylated liposomes.  Incorporating Fe2+ or 
porphyrin in the liposome compositions did not increase the sensitivity toward hydrogen 
peroxide because the iron was partially oxidized during the heat/thaw cycles in the 
formulation step.  Moreover, adding excess Fe2+ in the liposomes resulted in precipitation 
during ultrasound testing.  We found that the optimal liposome composition is 80 % 
DSPC, 10 % DPPA and 10 % DPPE-PEG5K (10 mg/mL).  The final concentrations of 
liposomes and allylhydrazine were diluted 10 times during ultrasound testing.  The 
acoustic response of allylhydrazine encapsulated within liposome with the hydroxyl 
radical is summarized in Table 6. 
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Table 6. Acoustic response of allylhydrazine encapsulated within various liposome 






20mM 10uM 0.1 40 37oC 3.1
20mM 1uM 0.1 40 37oC 1.3
20mM 0uM 0.1 40 37oC 1.5
10mM 100uM 0.1 40 37oC 23.3
10mM 10uM 0.1 40 37oC 9.4
10mM 1uM 0.1 40 37oC 4.3
10mM 0uM 0.1 40 37oC 2.9
10mM 10uM 0.1 40 37oC 1.9
50mM 1uM 0.1 40 37oC 3.8
50mM 0uM 0.1 40 37oC 4.0
20mM 10uM 0.1 40 37oC 12.4
20mM 1uM 0.1 40 37oC 7.2
20mM 0uM 0.1 40 37oC 6.9
20mM 10uM 0.1 40 37oC 5.4
20mM 1uM 0.1 40 37oC 7.5
20mM 0uM 0.1 40 37oC 7.4
20mM 1uM 0.1 40 37oC 7.2
20mM 0uM 0.1 40 37oC 1.1
20mM 1uM 0.1 40 22oC 6.3
20mM 0uM 0.1 40 37oC 2.9
20mM 1mM 0.4 20 37oC 9.9
20mM 10uM 0.4 20 37oC 2.6
20mM 0uM 0.4 20 37oC 2.2
20mM 1mM 0.1 40 37oC 5.7
20mM 10uM 0.1 40 37oC 2.1
20mM 1uM 0.1 40 37oC 1.5
20mM 0uM 0.1 40 37oC 1.7
20mM 10uM 0.1 40 37oC 2.4
20mM 1uM 0.1 40 37oC 7.0
20mM 0uM 0.1 40 37oC 7.7
10mM 1mM 0.1 40 37oC 6.0
10mM 100uM 0.1 40 37oC 4.4
DPPA/DPPE/DPPC (0.4mg/mL)
DPPA/DPPC/DPPE-PEG5K (1mg/mL)













We examined if the APLs would produce a stronger acoustic signal in response to 
radical oxidants compared to free allylhydrazine.  Figure 5.2 shows that the APLs are 
more effective at detecting the hydroxyl radical than free allylhydrazine in vitro, and 
displays a linear correlation between ultrasound intensity and the hydroxyl radical 
concentration within the concentration range of 10 µM - 1 mM (R2 = 0.97).  For example, 
for a 10 µM hydroxyl radical concentration the ultrasound intensity of the APLs 
increased 5.6 fold compared to only 1.6 fold for free allylhydrazine.  Therefore, the APLs 





































Figure 5.2. Acoustic response of allylhydrazine encapsulated within liposomes (APLs) 
showing linear correlation between ultrasound intensity and hydroxyl radical 
concentrations 
 
Some phospholipids can trap gas bubbles during the preparation of the liposomes 
and induce echogenicity.  Therefore, to investigate if liposomes alone contributed to an 
increase in ultrasound signal, empty liposomes with the same compositions as the APLs 
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(but without allylhydrazine) were investigated with various concentrations of H2O2 and 
Fe2+ (1 mM).  No increase in ultrasound intensity was observed, confirming that the 
liposomes themselves did not contribute to the increase in ultrasound echogenicity.  
Comparison of empty liposomes with the APLs demonstrated that allylhydrazine is the 
































Figure 5.3. Hydroxyl radical added to empty liposomes did not show increase in 
ultrasound intensity 
 
To investigate the specificity of the APLs toward the hydroxyl radical versus 
hydrogen peroxide, various H2O2 concentrations (10 µM, 100 µM and 1 mM) were added 
to the APLs with 100 mM allylhydrazine.  Figure 5.4 showed that adding only H2O2 
(without Fe2+) to the APLs did not increase the ultrasound signal.  This study 


































Figure 5.4. Control experiments demonstrating that the APLs are specific toward the 
hydroxyl radical.  The APLs (100 mM) were mixed with various H2O2 concentrations (10 
µM, 100 µM, 1 mM) with Fe2+ versus without Fe2+.  The acoustic response showed that 
the ultrasound intensity increase with H2O2 and Fe2+, but not with H2O2 alone. 
 
5.3.3 In vivo biodistribution of liposomes 
To determine the biodistribution of the liposomes, the mice were injected with 
APL-based liposomes loaded with IR-786 dye and sacrificed after 10 minutes.  Figure 
5.5 revealed that strong fluorescence were present in the liver and lung (upper right: 
bright field, lower left: near-infrared, upper left: merged image).  This result confirmed 
that the liposomes can reach the liver within 10 minutes, which is a suitable timeframe 
for clinical ultrasound imaging. 
 77
 
Figure 5.5. Fluorescence imaging revealed that liposomes loaded with IR-786 dye can 
reach the liver in 10 minutes 
 
We also examined if the liposomes only remained in the circulation or also 
accumulated in the tissue.  After the mice were sacrificed, the heart, liver, lung and 
kidney were perfused with saline and harvested.  As a control to remove auto-
fluorescence, the organs from another mouse injected with saline were also harvested and 
placed in a Petri dish for comparison.  Figure 5.6 showed that the organs from the mouse 
injected with liposomes loaded with IR-786 dye (left column) revealed stronger 
fluorescence than the organs from the control mouse injected with saline (right column).  
The fluorescence image also revealed that more liposomes accumulated in the liver and 
the lung than the heart or the kidney (upper right: bright field, lower left: near-infrared, 




Figure 5.6. Fluorescence imaging liposomes loaded with IR-786 in the heart, liver, lung 
and kidney 
 
In a separate study, the biodistribution of the liposomes was determined by 
injecting APL-based liposomes loaded with Rhodamine B dye intravenously into mice (n 
= 3).  The mice were sacrificed after 10 minutes, and Figure 5.7 showed that large 
amount of liposomes accumulated in the liver, followed by the lung, the heart and the 
kidney.  The Rhodamine B absorbance was normalized by tissue weight and compared to 




































Figure 5.7. Biodistribution of APL-based liposomes loaded with Rhodamine B dye 10 
minutes after injection   
 
5.4 Discussion 
5.4.1 Acoustic improvement of liposomal encapsulation  
We expected enhanced bubble stability and stronger ultrasound signal from the 
APLs compared to free allylhydrazine for the same hydroxyl radical concentration.  We 
also expected that longer phospholipid chain can provide more resistance against bubble 
dissolution by reducing the membrane permeability of gas.  We found that DSPC (18C) 
was the optimal chain length with DPPA (16C) and DPPE-PEG5k (16C).  
Both charged phospholipid and PEGylated liposomes can enhance bubble 
stability by improving bubble dispersion.  However, we noticed that when PEGylated 
liposomes exceeded 10 mol % of the total liposome composition, they could come off of 
the liposomes and formed micelles on their own.   
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5.4.2 Biodistribution of liposomes and in vivo implication 
The biodistribution studies showed that the liposomes can reach the liver within 
10 minutes and accumulate locally.  Since macrophages are the major sources of radical 
oxidants production in the body and they mostly reside in the liver, we expect that the 
liver could be a suitable organ for in vivo imaging of oxidative stress.  The lung is another 
major source of macrophage, as confirmed by the in vivo biodistribution study.  However, 
the lung is filled with air sacs that will generate strong background during ultrasound 
imaging, and this could present challenges for in vivo study.  The heart and the kidney did 
not exhibit significant accumulation of liposomes in vivo, so they are were not considered 
in the present study. 
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 CHAPTER 6 
IN VIVO IMAGING OF OXIDATIVE STRESS USING CLINICAL 
ULTRASOUND SYSTEM 
6.1 Introduction 
Reactive oxygen species are associated with many diseases, and the ability to 
detect oxidative stress in vivo can enhance the diagnosis of many diseases at an early 
stage.  In order to assess the feasibility of using gas-forming reaction to image oxidative 
stress in vivo with ultrasound, several studies were performed.  The goal of these studies 
was to apply the in vitro characterization under appropriate in vivo conditions, which are 
very dynamic and complex. 
The first task is to determine if bubbles can be generated from the oxidation of 
allylhydrazine with radical oxidants inside the intraperitoneal (IP) cavity of mice and also 
be imaged with a clinical ultrasound system.  Since the abdominal region is full of gastric 
gases, we need to determine if ultrasound can differentiate the signal from bubble 
nucleation versus the background.  To examine this issue, allylhydrazine and hydroxyl 
radical were injected locally into the mice IP cavity, and the video intensity was recorded 
for 10 minutes.  Detail results are discussed in the chapter. 
For in vivo studies involving oxidative stress, the liver is a suitable organ for 
ultrasound imaging because: 1) the large size of liver makes it easy to identify, and 2) the 
liver is composed of tissue filled with vasculature and no air gaps, so it should present 
low background signal during ultrasound imaging, and 3) liver macrophages are a major 
source of ROS production in the body, and animal studies that induce inflammation in the 
liver are well-established.  Hence, a Lipopolysaccharide (LPS) model of inflammation 
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was used to investigate the feasibility of imaging oxidative stress in vivo with 
allylhydrazine. 
Our in vivo studies demonstrate that allylhydrazine can image oxidative stress in 
mice liver with good spatial resolution.  To enhance targeting to the liver and to improve 
bubble stability, allylhydrazine was encapsulated inside phospholipid liposomes (APLs).  
The rationale for this approach was confirmed by both in vitro acoustic characterization 
and in vivo biodistribution studies described in the previous chapter.  The in vivo studies 
using the APLs to image oxidative stress displayed improvement with reduction in 
background signal.  Appropriate controls were also examined by injecting empty 
liposomes in mice treated with LPS to confirm that the ultrasound signal was not 
generated by empty liposomes or inflammation alone.  Finally, a clinical contrast agent, 
Definity was used as a comparison with the results from in vivo studies using the APLs. 
 
6.2 Materials and Methods 
6.2.1 In vivo study with intraperitoneal injection of allylhydrazine and hydroxyl 
radical 
Two C57Bl/6 male mice, aged 8-10 weeks, were house-bred in Emory University 
Animal Care facility.  The mice were anaesthetized with isofluorane and the fur on the 
chest and abdomen was removed.  Two clay-dough potties were pressed against the mice 
abdomen from both sides to stabilize the mice.  An ultrasound probe was placed 
horizontally across the ventral surface of the mice intraperitoneal (IP) cavity.  In the first 
study, 4 mL saline was injected into the IP cavity of the mice using an insulin syringe, 
followed by injection of 1 mL allylhydrazine (1 M).  Next, 0.5 mL of H2O2 (10 mM) and 
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0.5 mL Fe2+ (10 mM) were injected into the IP cavity with an insulin syringe, and 
constituted a final hydroxyl radical concentration of 1 mM inside the IP cavity. 
In the second study, lower hydroxyl radical concentration was investigated, and 4 
mL saline was injected into the IP cavity of the mice using an insulin syringe, followed 
by injection of 1 mL allylhydrazine (1 M).  Next, 0.5 mL of H2O2 (1 mM) and 0.5 mL 
Fe2+ (10 mM) were injected into the IP cavity with an insulin syringe, and constituted a 
final hydroxyl radical concentration of 86 μM inside the IP cavity. 
The IP cavity was imaged using a 14 MHz Siemens Acuson Sequoia 512 clinical 
ultrasound system (Siemens, USA) at various time points before and after each injection 
(MI = 0.05, 187 kPa pressure, 1.5 cycle pulses and 70 Hz pulse repetition frequency).  
The ultrasound transmitted power was minimized and a linear relationship between 
transmitted power (dB) and video intensity was observed.  DICOM image data were 
processed with ImageJ software (NIH).  All animal studies were conducted under a 
protocol that was approved by the Animal Use and Care Committee of Emory University.  
 
6.2.2 In vivo LPS model with allylhydrazine  
Two groups of C57Bl/6 male mice (n = 5 per group), aged 8-10 weeks, were 
obtained from Jackson Labs.  Inflammation was induced by injecting 200 µL of LPS in 
saline (2 mg/mL) into the peritoneal cavity of the mice, 200 µL of saline was injected 
into control mice.  20 hours later the mice were anaesthetized with isofluorane and the fur 
on the chest and abdomen was removed.  An ultrasound probe was placed horizontally 
across the ventral surface of the mice chest, and 100 µL of allylhydrazine solution (14 
mg/mouse) was injected intravenously into the retro-orbital capillary bed.  The mouse 
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liver was imaged using a 14 MHz Siemens Acuson Sequoia 512 clinical ultrasound 
system (Siemens, USA) for 10 minutes after allylhydrazine injection (MI = 0.05, 187 kPa 
pressure, 1.5 cycle pulses and 70 Hz pulse repetition frequency).  The ultrasound 
transmitted power was minimized and a linear relationship between transmitted power 
(dB) and video intensity was observed.  DICOM image data were processed with ImageJ 
software (NIH).  The region of interest in the liver was analyzed and the mean video 
intensity was normalized.  All animal studies were conducted under a protocol that was 
approved by the Animal Use and Care Committee of Emory University.  All treatment 
groups were analyzed for statistical significance (*p < 0.05) by an unpaired t-test. 
 
6.2.3 In vivo LPS model with allylhydrazine encapsulated in liposomes 
Two groups of C57Bl/6 male mice (n = 5 per group), aged 8-10 weeks, were 
obtained from Jackson Labs.  Inflammation was induced by injecting 200 µL of LPS in 
saline (2 mg/mL) into the peritoneal cavity of the mice, 200 µL of saline was injected 
into control mice.  20 hours later the mice were anaesthetized with isofluorane and the fur 
on the chest and abdomen was removed.  An ultrasound probe was placed horizontally 
across the ventral surface of the mice chest, and 100 µL of APLs (14 mg 
allylhydrazine/mouse) was injected intravenously into the retro-orbital capillary bed.  The 
mouse liver was imaged using a 14 MHz Siemens Acuson Sequoia 512 clinical 
ultrasound system (Siemens, USA) for 10 minutes after the APLs injection (MI = 0.05, 
187 kPa pressure, 1.5 cycle pulses and 70 Hz pulse repetition frequency).  The ultrasound 
transmitted power was minimized and a linear relationship between transmitted power 
(dB) and video intensity was observed.  DICOM image data were processed with ImageJ 
 85
software (NIH).  The region of interest in the liver was analyzed and the mean video 
intensity was normalized.  To investigate if the increase in ultrasound signals was due to 
the radicals reacting with allylhydrazine inside the liposomes and not due to the tissue 
becoming more echogenic during inflammation, empty liposomes (without 
allylhydrazine) were injected into mice treated with LPS after 20 hours, and the mice 
were imaged with a clinical ultrasound system.  All animal studies were conducted under 
a protocol that was approved by the Animal Use and Care Committee of Emory 
University.  All treatment groups were analyzed for statistical significance (*p < 0.05) by 
an unpaired t-test. 
 
6.2.4 Comparison with clinical contrast agents (Definity) 
Two C57Bl/6 male mice, aged 8-10 weeks, were obtained from Jackson Labs.  
The mice were anaesthetized with isofluorane and the fur on the chest and abdomen was 
removed.  An ultrasound probe was placed horizontally across the ventral surface of the 
mice chest.  The mice liver was imaged using a 14 MHz Siemens Acuson Sequoia 512 
clinical ultrasound system (Siemens, USA) with fixed ultrasound settings (MI = 0.05, 187 
kPa pressure, 1.5 cycle pulses and 70 Hz pulse repetition frequency). 
In the first study, 50 μL of Definity (1000 x dilution) was injected intravenously 
into the retro-orbital capillary bed.  The mice liver was imaged before and after each 
injection at various time points (0, 1, 2, 3, 5, 7, 10 min).  In the second study, 50 μL of 
Definity (1000 x dilution) was injected intravenously into the retro-orbital capillary bed.  
The mice liver was imaged with both B-mode and Doppler imaging before and after each 
injection at various time points (0, 1, 2, 3, 5, 7, 10 min). 
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The ultrasound transmitted power was minimized and a linear relationship 
between transmitted power (dB) and video intensity was observed.  DICOM image data 
were processed with ImageJ software (NIH).  All animal studies were conducted under a 
protocol that was approved by the Animal Use and Care Committee of Emory University.  
 
6.3 Results 
6.3.1 Ultrasound imaging of bubble nucleation inside intraperitoneal cavity of mice  
We investigated if the reaction of allylhydrazine with the hydroxyl radical can 
generate bubbles inside the mice IP cavity and be detected with a clinical ultrasound 
system.  Figure 6.1 (A-F) shows that mice injected with allylhydrazine (100 mM) and 
the hydroxyl radical (1 mM) generated detectable amount of bubbles almost immediately 
after the hydroxyl radical injection.  Increase in video intensity (brighter image) 
corresponds with stronger echogenicity.  Fig. 6.1 (A) shows the mice IP cavity before 
injection, and Fig. 6.1 (B) shows the mice cavity after the injection of 4 mL of saline, and 
the skin bulged upward due to the fluid pressure.  The dark background in the IP cavity is 
the fluid, and the bright spot in the middle of the IP cavity is the tip of needle.  In Fig. 6.1 
(C), bubble formation was observed immediately following the injection of 
allylhydrazine and the hydroxyl radical, as shown by the bright spots (indicated by the 
arrow) in the IP cavity.  Figure 6.1 (D-F) shows that the video intensity increased 








(D) 2 min after hydroxyl radical 
injection 
(C) Injection of allylhydrazine (1 M) 
and 1 mL Fe2+ + H2O2 (1 mM) at 0 min 
 
  
Figure 6.1. Injection of allylhydrazine (100 mM) and hydroxyl radical (1 mM) inside 
mouse IP cavity  
(E) 5 min after hydroxyl radical 
injection 





We next investigated if bubble formation could be generated at lower hydroxyl 
radical concentration and also be detected with ultrasound.  Figure 6.2 (A-F) shows that 
mice injected with allylhydrazine (100 mM) and the hydroxyl radical (86 μM) generate 
significant amount of bubbles immediately after injection.  Fig. 6.2 (A) shows the mice 
IP cavity before injection.  Fig. 6.2 (B) shows the mice cavity after the injection of 4 mL 
saline, and the skin bulged upward due to the fluid pressure.  The dark background in the 
IP cavity is the fluid, and the bright spot in the middle of the IP cavity is the tip of needle.  
Fig. 6.2 (C) shows the mice IP cavity after injection of allylhydrazine.  In Fig. 6.2 (D) 
bubble formation was observed immediately following the injection of allylhydrazine and 
the hydroxyl radical, as shown by the bright spots in the IP cavity (indicated by the 
arrow).  Figure 6.2 (E-F) shows that the video intensity increased continually for 10 
minutes until the IP cavity is filled with bubbles.  Comparing with the results from 1 mM 
hydroxyl radical concentration (Fig. 6.1), significant bubble formation can still be 












Figure 6.2. Injection of allylhydrazine (100 mM) and the hydroxyl radical (86 μM) inside 
mouse IP cavity 
(F) 10 min after hydroxyl radical 
injection 
(E) 2 min after hydroxyl radical 
injection 
(D) Injection of 1 mL Fe2+ + H2O2 
(final concentration = 86 μM) at 0 min 
(C) Injection of 1 mL allylhydrazine 




6.3.2 In vivo imaging of oxidative stress using allylhydrazine  
We investigated the in vivo feasibility of using allylhydrazine to image oxidative 
stress in mice, triggered by an LPS-induced inflammatory response.  Mice were given an 
intraperitoneal injection of LPS, or saline as a control.  Allylhydrazine (14 mg/mouse) 
was injected intravenously into the retro-orbital capillary bed of the mice 20 hours later.  
The mice were then imaged with a Siemens Acuson Sequoia 512 clinical ultrasound 
machine at a 14 MHz frequency.  Figure 6.3 demonstrates that allylhydrazine can 
enhance acoustic contrast in mice experiencing oxidative stress.  For example, 10 minutes 
after allylhydrazine injection, the livers of LPS-treated mice became significantly 
brighter, in comparison to mice treated with saline (Fig. 6.3 B). 
We performed quantitative analysis on the ultrasound images and Figure 6.4 
shows that after 10 minutes, the normalized mean video intensity of LPS-treated mice 
increased by 60%, compared to a 30% increase for mice treated with saline.  The 
normalized mean video intensity was determined by comparing the video intensity of the 
liver at 0 min and 10 min after the allylhydrazine injection.  We expected that the 30% 
increase in background signal observed in saline-treated mice was due to the reaction of 
allylhydrazine with mitochondrial radical oxidants produced by metabolism [1].  The 
enhancement in ultrasound intensity indicated that allylhydrazine reacted with radical 
oxidants in vivo and generated gas forming molecules.  These results also demonstrated 
that allylhydrazine can detect oxidative stress in vivo with 3D spatial resolution that 







0 min 10 min  
Figure 6.3. Representative ultrasound images of mice livers treated with allylhydrazine 
and LPS versus treatment with allylhydrazine and saline.  Ultrasound images were taken 
at 0 min and 10 min after the allylhydrazine injection.  The lower panel shows the entire 
cross-section area of the mice chest, and the upper panel shows the zoom-in area of the 
liver. 
 (A) Mice treated with LPS and allylhydrazine.  Representative ultrasound images of the 
mouse liver show enhanced acoustic contrast after 10 minutes after the allylhydrazine 
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(B) Mice treated with saline and allylhydrazine.  Representative ultrasound images of the 






































Figure 6.4. Quantitative analysis of the ultrasound images in Fig. 6.3 A and B 
demonstrated that mice treated with allylhydrazine and LPS increased their normalized 
mean video intensity by 60% (circles), compared to a 30% increase in control mice 
treated with allylhydrazine and saline (squares).  The vertical bars represent standard 
error. 
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6.3.3 In vivo imaging of oxidative stress using allylhydrazine encapsulated within 
liposomes 
We investigated if the APLs are more effective than free allylhydrazine for 
imaging oxidative stress in vivo with an LPS model of inflammation.  We first verified 
that the liposome formulation used to generate the APLs were capable of targeting the 
liver within 10 minutes (Fig. 5.7).  Mice were given an intraperitoneal injection of LPS, 
or saline as a control, and the APLs (14 mg allylhydrazine/mouse) were injected 
intravenously into the retro-orbital capillary bed 20 hours later.  The mice were imaged 
with a Siemens Acuson clinical ultrasound system at a 14 MHz frequency.  Figure 6.5 
illustrates that APLs can enhance acoustic contrast in mice experiencing oxidative stress 
while maintaining a low background signal in healthy mice.  For example, 10 minutes 
after the APL injection, several bright spots became visible in the livers of LPS-treated 
mice (Fig. 6.5 A), but not in mice treated with saline (Fig. 6.5 B). 
We performed quantitative analysis on the ultrasound images and Figure 6.6 
shows that after 10 minutes, the normalized mean video intensity of LPS-treated mice 
increased by 40%, but remained at baseline intensity levels for mice treated with saline.  
We also verified that the injection of empty APL-based liposomes (at the same lipid 
concentration used in Fig. 6.5) into LPS-treated mice (n = 5) did not produce enhanced 
ultrasound echoes, demonstrating that inflammation in tissue alone did not enhance 
ultrasound echoes.  Together, these results demonstrated that the APLs can reduce the 
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0 min 10min  
Figure 6.5. Representative ultrasound images of mice livers treated with the APLs and 
LPS versus mice treated with the APLs and saline.  Ultrasound images were taken at 0 
min and 10 min after the APLs injection.  The lower panel shows the entire cross-section 
area of the mice chest, and the upper panel shows the zoom-in area of the liver. 
 (A) Mice treated with LPS and the APLs.  Representative ultrasound images of the 
mouse liver show enhanced acoustic contrast 10 minutes after the APLs injection.  Arrow 
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(B) Mice treated with saline and the APLs.  Representative ultrasound images of the 







































Figure 6.6. Quantitative analysis of the ultrasound images in Fig. 6.5 A and B 
demonstrated that mice treated with the APLs and LPS increased their normalized mean 
video intensity by 40% (circles), compared to no increase in control mice treated with the 
APLs and saline (squares).  In addition, quantitative image analysis of mice treated with 
LPS and empty liposomes (n = 5) did not show an increase in normalized mean video 
intensity (triangles).  The vertical bars represent standard error. 
6.3.4 Comparison with clinical contrast agent (Definity) 
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A clinical contrast agent, Definity was used as a positive control for comparison 
with our in vivo studies.  Definity is composed of a perfluoropropane gas core and a 
PEGylated phospholipid shell with similar composition as the liposomes used in our in 
vivo studies with the APLs.  The Definity solution was diluted before injection into mice 
to match the same clinical dosage for human.  All the ultrasound settings remained the 
same to compare the imaging results of Definity with the APLs. 
Figure 6.7 (A) shows an ultrasound image of a normal mice liver before 
injection, and Figure 6.7 (B) shows an ultrasound image immediately after the injection 
of 50 µL Definity.  The video intensity inside the liver decreased significantly to a dark 
background with B-mode imaging.  Figure 6.7 (C) and (D) show that the ultrasound 









(C) 5 min after Definity injection (B) 10 min after Definity injection  
Figure 6.7. B-mode imaging of mice liver after intravenous injection of clinical contrast 
agent Definity.  
 
At first, it was not clear what caused the decrease in video intensity immediately 
after Definity injection, and how the image restored to its original video intensity after 10 
minutes.  Since Definity was expected to provide stronger ultrasound signal under 
contrast mode, the Doppler-mode was used in the second study.  The same amount of 
Definity solution (50 μL) was injected into mice intravenously.  The ultrasound settings 
remained the same, except for the additional turning on of Doppler mode imaging at 
fixed time intervals.  Figure 6.8 (A) shows an ultrasound image of a normal mice liver 
before injection, and Figure 6.8 (B) shows an ultrasound image immediately after 
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injection of 50 uL Definity.  Figure 6.8 (C) shows an inset of Doppler imaging in the 
liver, and strong Doppler shifts are indicated by the intense blue and red color in the 
image.  Figure 6.8 (D) shows the B-mode imaging of mice liver 1 min after injection, 
and Figure 6.8 (E) shows the Doppler-mode imaging at the same time interval.  Strong 
Doppler shift can still be detected after 1 minute.  Figure 6.8 (F) and (G) traced the 
restoration of video intensity in the mice liver with B-mode imaging after 5, and 10 
minutes.  Doppler imaging is used to characterize flow and the Doppler shift can be 
intensified when gas bubbles are flowing in the blood vessel.  This result showed that 
Definity contrast agent can reach the liver, but was only visible through Doppler-mode 
imaging. 
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(C) Doppler imaging at 
t = 10 s  
(B) Injection of Definity 
at t = 0 min 
(A) Mice liver before 
injection 
 
   
  




(F) 5 min after Definity injection (G) 10 min after Definity injection 
Figure 6.8. B-mode and Doppler imaging of mice liver after intravenous injection of 




6.4.1 In vivo imaging of oxidative stress using clinical ultrasound system 
The ability of allylhydrazine to detect ROS was investigated in vivo using a LPS 
model of inflammation.  Our in vivo studies demonstrate that allylhydrazine can image 
oxidative stress in mice liver with good spatial resolution (Figure 6.3).  Moreover, a 10 
minute time-frame for imaging is reasonably fast and suitable for clinical applications, 
where imaging procedure can take minutes to hours.  Quantitative analysis of the 
ultrasound images (Figure 6.4) shows that after 10 minutes, the normalized mean video 
intensity of LPS-treated mice increased by 60%, compared to an only 30% increase for 
mice treated with saline.  We expect that the 30% increase in background signal observed 
in saline-treated mice was due to the reaction of allylhydrazine with mitochondrial radical 
oxidants produced by metabolism [1].  Since liver macrophages are a major source of 
ROS production in the body, allylhydrazine may react with the ROS in the liver of 
healthy mice.  The enhancement in ultrasound intensity indicated that allylhydrazine 
reacted with radical oxidants in vivo and generated gas forming molecules.  These results 
also demonstrated that allylhydrazine can detect oxidative stress in vivo with 3D spatial 
resolution that cannot be achieved using fluorescent [33] or chemiluminescent [35] based 
contrast agents. 
 
6.4.2 In vivo enhancement of liposomal encapsulation 
To enhance targeting to the liver and to improve bubble stability, allylhydrazine 
was encapsulated inside phospholipid liposomes.  Both in vitro acoustic characterization 
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and in vivo biodistribution studies confirmed our hypothesis (Figures 5.2 and 5.7).  The 
in vivo studies using the APLs to image oxidative stress displayed similar results with 
using free allylhydrazine.  Incidentally, this approach also has the benefit of reducing the 
background signal in healthy mice, possibly because the allylhydrazine were released 
from the APLs to react with the ROS after been endocytosed by activated macrophages, 
and there were fewer activated macrophages in the liver of healthy mice to endocytose 
the APLs. 
There are, however, limitations to our in vivo studies, and it is difficult to 
extrapolate in vivo outcomes from in vitro behavior due to various factors such as the 
spatiotemporal distribution of the APLs, extravasation from blood circulation, and 
internalization by different cell population.  The sensitivity of allylhydrazine toward ROS 
under in vivo conditions may be different from in vitro environment, and other 
biomolecules could compete with ROS to react with allylhydrazine and reduce its 
effective concentration.  Furthermore, physical forces such as viscosity and fluid flow 
will also affect bubble formation and ultrasound detection.  For example, Ferrara et. el. 
showed that phagocytosed microbubbles experienced viscous damping inside neutrophil 
[58], and concluded that contrast-enhanced ultrasound can detect distinct acoustic signals 
from microbubbles inside the neutrophil.  This means that it is harder to nucleate bubble 
within intracellular medium compared to extracellular medium.  On the other hand, 
microbubble-specific imaging sequences have been designed by varying imaging 
parameters such as the acoustic power, the transmit and receive frequencies, the pulse 
frequency, the pulse phase and amplitude.  Optimization of these parameters is required 
for different contrast agents to obtain the best diagnostic performance [62]. 
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CHAPTER 7 
SUMMARY AND FUTURE DIRECTIONS 
7.1 Overall Summary 
The overproduction of ROS is associated with numerous diseases, and the ability 
to detect oxidative stress in vivo in a clinical setting has the potential to significantly 
improve the diagnosis of human diseases.  Hence, the development of ultrasound imaging 
probes that detect ROS can have a great impact on translational medicine.  The overall 
objective of this thesis is to develop a new ultrasound contrast agent that has the physical 
and chemical properties needed to image ROS in vivo.  This work presents a new 
approach to perform ultrasound imaging of oxidative stress in vivo via chemical reactions 
that generate gas forming molecules in the presence of ROS.  The key issues for this 
strategy to be successful are: 1) the kinetics of gas generation should be faster than gas 
diffusion for bubbles to nucleate, 2) the sensitivity of ultrasound to detect gas formation 
from chemical reactions, and 3) translating this approach into more complex and dynamic 
conditions in vivo. 
Here, we demonstrate that ROS can be imaged with allylhydrazine by ultrasound.  
Allylhydrazine is designed to nucleate gas bubbles in ROS-producing tissues, and the 
bubbles produce strong acoustic echoes that can be detected by ultrasound.  In addition, 
allylhydrazine was encapsulated within liposomes to improve the in vivo efficacy by 
increasing bubble stability and targeting the liver macrophages, which are the major 
source of pathogenic ROS production. 
The major contribution of this work is transforming a sequence of complex 
chemical reactions from in vitro characterization to in vivo applications under 
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physiological conditions.  We demonstrated that the kinetics of gas generation was 
sufficiently fast for bubble nucleation and physiological concentrations of radical oxidant 
could be detected by ultrasound in a clinical setting (Aim I; Chapters 3 and 4).  We also 
showed that the in vivo efficacy of allylhydrazine was enhanced by liposome 
encapsulation (Aim II; Chapter 5).  Finally, we show that oxidative stress can be detected 
in vivo with clinical ultrasound system (Aim III; Chapter 6).  Therefore, imaging ROS 
with gas-forming reaction could have translational impact on clinical ultrasound 
diagnostics. 
 
7.2 Aim I: Ultrasound Detection of Chemically Generated Microbubbles 
The objectives of this aim were to design appropriate chemical reactions that can 
generate gas bubbles in the presence of radical oxidants and to investigate the feasibility 
of ultrasound detection.  Allylhydrazine and its analogs were investigated, and the 
oxidation kinetics of allylhydrazine showed that it possessed suitable kinetics to generate 
bubbles under physiological conditions.  Furthermore, bubble nucleation from the 
oxidation of allylhydrazine and radical oxidants was confirmed by optical observation 
and in vitro acoustic characterization.  The effect of various ultrasound parameters were 
studied using a custom-built ultrasound system and optimized, and a linear correlation 
between ultrasound intensity and the concentrations of radical oxidants was observed.  
We also found that ultrasound can detect small increment (1-2%) of gas concentration 
above supersaturation, and suggest that classical bubble nucleation theory overestimated 
the threshold for bubble nucleation. 
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7.3 Aim II: Liposomal Encapsulation and Stabilization of Microbubbles 
The objectives of this aim were to determine if encapsulating allylhydrazine 
within liposomes can improve bubble stability and enhance in vivo efficacy.  The effects 
of various liposome compositions on bubble nucleation were investigated, including lipid 
chain length, PEGlyation, incorporation of charged lipid and porphyrin, loading ratio of 
lipid to allylhydrazine, and liposomes formulation.  The in vitro acoustic response 
demonstrated that allylhydrazine encapsulated within liposomes displayed stronger 
ultrasound intensity than free allylhydrazine.  The in vivo biodistribution of liposomes 
showed that they can target the liver within 10 minutes, demonstrating clinical potential 
for in vivo application. 
 
7.4 Aim III: In Vivo Imaging of Oxidative Stress 
The objectives of this aim were to demonstrate in vivo imaging of oxidative stress 
using a clinical ultrasound system.  We first demonstrated that bubble nucleation could be 
imaged with ultrasound inside the intraperitoneal cavity of mice by direct local injection 
of allylhydrazine and hydroxyl radicals into the mice IP cavity.  Next, we demonstrated 
the feasibility of using allylhydrazine to image oxidative stress in vivo with clinical 
ultrasound system based on a LPS model of inflammation.  Ultrasound images indicated 
the presence of oxidative stress in the mouse liver with well-defined resolution, and 
quantitative image analysis indicated stronger ultrasound signal from mice treated with 
allylhydrazine and LPS compared to mice treated with allylhydrazine and saline.  We 
also demonstrated that the in vivo efficacy of allylhydrazine was improved by 
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encapsulation within liposomes.  Lastly, we investigated a clinical ultrasound contrast 
agent as a positive control. 
 
7.5 Conclusions 
The development of contrast agents that can image disease biomarkers in a 
clinical setting remains a major challenge.  Ultrasound contrast agents have tremendous 
diagnostic potential because of their excellent spatial resolution and the widespread 
clinical use of ultrasound.  Here, we demonstrate a new strategy for performing 
molecular imaging by ultrasound based on chemical reactions that generate gas forming 
molecules.  This approach was demonstrated with the imaging of ROS by an 
allylhydrazine-based contrast agent, termed the APLs.  The overproduction of radical 
oxidants is associated with many inflammatory diseases, and therefore the APLs have 
numerous potential applications.  Moreover, the concept of using gas-forming reactions 
for targeted ultrasound imaging opens up a new area for the development of ultrasound 
contrast agent outside of pre-formed gas bubbles.   
 
7.6 Future directions 
The current work demonstrated in vivo ultrasound imaging of oxidative stress in 
the liver based on a LPS model of inflammation.  We encapsulated allylhydrazine inside 
various liposomes compositions (e.g. APLs), and showed that the liposomes can target 
the liver.  Many other diseases associated with ROS such as arthritis, cardiovascular 
disease, renal ischemia-reperfusion, and muscular inflammation can also be explored 
with our present approach.  However, further studies are needed to investigate the APLs’ 
ability to target areas outside the liver, and to differentiate intracellular versus 
extracellular response of the APLs.  Encapsulating allylhydrazine inside liposomes has 
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another benefit because toxicity related to allylhydrazine could be another issue for 
clinical applications, and the current strategy can be optimized by reducing the amount of 
allylhydrazine used in vivo while maintaining sufficient levels of ultrasound signal. 
Moreover, the concept of using gas-forming reactions to perform molecular 
imaging can be applied to other biomarkers.  Numerous biologically important 
molecules, such as enzymes, thiols [109], and the hydronium ion (pH) [54] participate in 
chemical reactions that generate gas forming molecules, and can potentially be imaged by 
ultrasound through carefully-designed gas-forming chemistry.  Finally, optimization of 
ultrasound parameters such as harmonic imaging can enhance the detection of acoustic 
signals specific to bubble nucleation in clinical setting. 
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APPENDIX A 
CLINICAL ULTRASOUND SYSTEM AND CALIBRATION 
Clinical Ultrasound system calibration 
A calibration was performed to ensure that the clinical ultrasound system operates 
in the linear range and that the video intensity increases linearly with ultrasound intensity.  
The correlation between the ultrasound power, mechanical index and gain settings were 
characterized.  The mechanical index was determined by stepping up the ultrasound 
power from -30 dB to -10 dB.  
To determine the optimal power or mechanical index the ultrasound imaging, a 25 
gauge stainless steel needle was used as a reference.  The mean video intensity of the 
reference was measured and the ultrasound power was increased from -30 dB to -10 dB.  
Two different gain setting were used (-20 dB and -7 dB) to determine if the video 
intensity reaches saturation. 
After the linear ranges for mechanical index and gain level have been determined, 
we tried to minimize the background signal was minimized while maintaining adequate 
ultrasound gain at MI = 0.05.  The ultrasound power was chosen to provide the best 
contrast for the ultrasound image. 
The conversion between mechanical index and ultrasound power was plotted in 
Figure A.1.  Since all the ultrasound experiments were performed at MI = 0.05, this 






















Figure A.1. Conversion between mechanical index (MI) and ultrasound power  
 
Figures A.2 and A.3 show that the video intensity is linearly proportional to the 
ultrasound power at two different gain settings.  Based on these characterization, the 
















































Figure A.3. Linear relationship between mean video intensity and power at -7 dB gain 
 
Figure A.4 shows the correlation between the mean video intensity and 





















Figure A.4. Linear relationship between video intensity and gain at MI = 0.05 
 110
REFERENCES 
1. Valko, M., et al., Free radicals and antioxidants in normal physiological 
functions and human disease. Int J Biochem Cell Biol, 2007. 39(1): p. 44-84. 
2. Harvey, C.J., et al., Advances in ultrasound. Clin Radiol, 2002. 57(3): p. 157-77. 
3. Kaufmann, B.A. and J.R. Lindner, Molecular imaging with targeted contrast 
ultrasound. Curr Opin Biotechnol, 2007. 18(1): p. 11-6. 
4. Weismann, C.F., et al., Three-dimensional targeting: a new three-dimensional 
ultrasound technique to evaluate needle position during breast biopsy. Ultrasound 
Obstet Gynecol, 2000. 16(4): p. 359-64. 
5. Bloch, S.H., P.A. Dayton, and K.W. Ferrara, Targeted imaging using ultrasound 
contrast agents. Ieee Engineering in Medicine and Biology Magazine, 2004. 
23(5): p. 18-29. 
6. Lindner, J.R., Microbubbles in medical imaging: current applications and future 
directions. Nature Reviews Drug Discovery, 2004. 3(6): p. 527-532. 
7. Correas, J.M., et al., Ultrasound contrast agents: properties, principles of action, 
tolerance, and artifacts. European Radiology, 2001. 11(8): p. 1316-1328. 
8. Kovacic, P., et al., Mechanism of mitochondrial uncouplers, inhibitors, and 
toxins: Focus on electron transfer, free radicals, and structure-activity 
relationships. Current Medicinal Chemistry, 2005. 12(22): p. 2601-2623. 
9. Klibanov, A.L., Targeted delivery of gas-filled microspheres, contrast agents for 
ultrasound imaging. Advanced Drug Delivery Reviews, 1999. 37(1-3): p. 139-
157. 
10. Christiansen, J.P., et al., Noninvasive imaging of myocardial reperfusion injury 
using leukocyte-targeted contrast echocardiography. Circulation, 2002. 105(15): 
p. 1764-1767. 
11. Willmann, J.K., et al., Targeted microbubbles for imaging tumor angiogenesis: 
Assessment of whole-body biodistribution with dynamic micro-PET in mice. 
Radiology, 2008. 249(1): p. 212-219. 
 111
12. Willmann, J.K., et al., US imaging of tumor angiogenesis with microbubbles 
targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology, 
2008. 246(2): p. 508-518. 
13. Weller, G.E.R., et al., Ultrasonic imaging of tumor angiogenesis using contrast 
microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. 
Cancer Research, 2005. 65(2): p. 533-539. 
14. Unger, E.C., et al., In vitro studies of a new thrombus-specific ultrasound contrast 
agent. American Journal of Cardiology, 1998. 81(12A): p. 58g-61g. 
15. Wright, W.H., et al., Evaluation of new thrombus-specific ultrasound contrast 
agent. Academic Radiology, 1998. 5: p. S240-S242. 
16. Dayton, P.A. and K.W. Ferrara, Targeted imaging using ultrasound. Journal of 
Magnetic Resonance Imaging, 2002. 16(4): p. 362-377. 
17. Rapoport, N., Z.G. Gao, and A. Kennedy, Multifunctional nanoparticles for 
combining ultrasonic tumor imaging and targeted chemotherapy. Journal of the 
National Cancer Institute, 2007. 99(14): p. 1095-1106. 
18. Korpanty, G., et al., Monitoring response to anticancer therapy by targeting 
microbubbles to tumor vasculature. Clinical Cancer Research, 2007. 13(1): p. 
323-330. 
19. Catalano, O., et al., Contrast-enhanced sonography of the spleen. American 
Journal of Roentgenology, 2005. 184(4): p. 1150-1156. 
20. Harvey CJ, L.A., Lynch M, Blomley MJK, Cosgrove DO, Application of 
ultrasound microbubbles in spleen, in Contrast media in ultrasonography: Basic 
principles and clinical applications, Q. E, Editor. 2005, Springer, Berlin Heidelberg 
New York. p. 205-219  
21. Thannickal, V.J. and B.L. Fanburg, Reactive oxygen species in cell signaling. 
American Journal of Physiology-Lung Cellular and Molecular Physiology, 2000. 
279(6): p. L1005-L1028. 
22. Finkel, T. and N.J. Holbrook, Oxidants, oxidative stress and the biology of 
ageing. Nature, 2000. 408(6809): p. 239-247. 
 112
23. Harman, D., Aging: a theory based on free radical and radiation chemistry. J 
Gerontol, 1956. 11(3): p. 298-300. 
24. Mccord, J.M. and Fridovic.I, Superoxide Dismutase an Enzymic Function for 
Erythrocuprein (Hemocuprein). Journal of Biological Chemistry, 1969. 244(22): 
p. 6049-&. 
25. Droge, W., Free radicals in the physiological control of cell function. 
Physiological Reviews, 2002. 82(1): p. 47-95. 
26. Turrens, J.F., Superoxide production by the mitochondrial respiratory chain. 
Bioscience Reports, 1997. 17(1): p. 3-8. 
27. Cadenas, E. and H. Sies, The lag phase. Free Radical Research, 1998. 28(6): p. 
601-609. 
28. Valko, M., et al., Role of oxygen radicals in DNA damage and cancer incidence. 
Molecular and Cellular Biochemistry, 2004. 266(1-2): p. 37-56. 
29. Boveris, A. and B. Chance, Mitochondrial Generation of Hydrogen-Peroxide - 
General Properties and Effect of Hyperbaric-Oxygen. Biochemical Journal, 1973. 
134(3): p. 707-716. 
30. Aikens, J. and T.A. Dix, Perhydroxyl Radical (Hoo.) Initiated Lipid-Peroxidation 
- the Role of Fatty-Acid Hydroperoxides. Journal of Biological Chemistry, 1991. 
266(23): p. 15091-15098. 
31. Valko, M., et al., Free radicals, metals and antioxidants in oxidative stress-
induced cancer. Chemico-Biological Interactions, 2006. 160(1): p. 1-40. 
32. Tanaka, K., et al., Rational design of fluorescein-based fluorescence probes. 
Mechanism-based design of a maximum fluorescence probe for singlet oxygen. J 
Am Chem Soc, 2001. 123(11): p. 2530-6. 
33. Gomes, A., E. Fernandes, and J.L.F.C. Lima, Fluorescence probes used for 
detection of reactive oxygen species. Journal of Biochemical and Biophysical 
Methods, 2005. 65(2-3): p. 45-80. 
 113
34. Rice, B.W., M.D. Cable, and M.B. Nelson, In vivo imaging of light-emitting 
probes. J Biomed Opt, 2001. 6(4): p. 432-40. 
35. Chen, W.T., C.H. Tung, and R. Weissleder, Imaging reactive oxygen species in 
arthritis. Mol Imaging, 2004. 3(3): p. 159-62. 
36. Lee, D., et al., In vivo imaging of hydrogen peroxide with chemiluminescent 
nanoparticles. Nat Mater, 2007. 6(10): p. 765-9. 
37. Scharlin, P., et al., Solubility of gases in water: Correlation between solubility 
and the number of water molecules in the first solvation shell. Pure and Applied 
Chemistry, 1998. 70(10): p. 1895-1904. 
38. Corey, E.J., et al., Stereospecific Total Synthesis of (+/-)-Cafestol. Journal of the 
American Chemical Society, 1987. 109(15): p. 4717-4718. 
39. Jabbari, A., E.J. Sorensen, and K.N. Houk, Transition states of the retro-ene 
reactions of allylic diazenes. Organic Letters, 2006. 8(14): p. 3105-3107. 
40. Price, J.D. and R.P. Johnson, Thermal Rearrangements of Cyclic Allenes Via 
Retro-Ene Reactions. Tetrahedron Letters, 1985. 26(21): p. 2499-2502. 
41. Benn, F.R., J. Dwyer, and I. Chappell, Ene Reaction of Maleic-Anhydride with 
Alkenes. Journal of the Chemical Society-Perkin Transactions 2, 1977(5): p. 533-
535. 
42. Stephenson, L.M. and D.L. Mattern, Stereochemistry of an Ene Reaction of 
Dimethyl Azodicarboxylate. Journal of Organic Chemistry, 1976. 41(22): p. 3614-
3619. 
43. Yu, Z.X. and K.N. Houk, Intramolecular 1,3-dipolar ene reactions of nitrile 
oxides occur by stepwise 1,1-cycloaddition/retro-ene mechanisms. Journal of the 
American Chemical Society, 2003. 125(45): p. 13825-13830. 
44. Calderwood, T.S., et al., Oxidation of Substituted Hydrazines by Superoxide Ion - 
the Initiation Step for the Autoxidation of 1,2-Diphenylhydrazine. Journal of the 
American Chemical Society, 1984. 106(17): p. 4683-4687. 
 114
45. Nanni, E.J. and D.T. Sawyer, Superoxide Ion Oxidation of Hydrophenazines, 
Reduced Flavins, Hydroxylamine, and Related Substrates Via Hydrogen-Atom 
Transfer. Journal of the American Chemical Society, 1980. 102(25): p. 7591-
7593. 
46. Misra, H.P. and I. Fridovich, Oxidation of Phenylhydrazine - Superoxide and 
Mechanism. Biochemistry, 1976. 15(3): p. 681-687. 
47. Itano, H.A. and J.L. Matteson, Mechanism of initial reaction of phenylhydrazine 
with oxyhemoglobin and effect of ring substitutions on the biomolecular rate 
constant of this reaction. Biochemistry, 1982. 21(10): p. 2421-6. 
48. Chern, C.I. and J.S. Filippo, Reaction of Superoxide with Hydrazines, 
Hydrazones, and Related Compounds. Journal of Organic Chemistry, 1977. 42(1): 
p. 178-180. 
49. Jones, S.F., G.M. Evans, and K.P. Galvin, Bubble nucleation from gas cavities - a 
review. Advances in Colloid and Interface Science, 1999. 80(1): p. 27-50. 
50. Blander, M. and J.L. Katz, Bubble Nucleation in Liquids. Aiche Journal, 1975. 
21(5): p. 833-848. 
51. Lubetkin, S.D., Why is it much easier to nucleate gas bubbles than theory 
predicts? Langmuir, 2003. 19(7): p. 2575-2587. 
52. Bowers, P.G., K. BarEli, and R.M. Noyes, Chemical oscillations and instabilities 
.100. Unstable supersaturated solutions of gases in liquids and nucleation theory. 
Journal of the Chemical Society-Faraday Transactions, 1996. 92(16): p. 2843-
2849. 
53. Finkelstein, Y. and A. Tamir, Formation of Gas-Bubbles in Supersaturated 
Solutions of Gases in Water. Aiche Journal, 1985. 31(9): p. 1409-1419. 
54. Rubin, M.B. and R.M. Noyes, Chemical Oscillations and Instabilities .77. 
Measurements of Critical Supersaturation for Homogeneous Nucleation of 
Bubbles. Journal of Physical Chemistry, 1987. 91(15): p. 4193-4198. 
 115
55. Klibanov, A.L., et al., Detection of individual microbubbles of ultrasound 
contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol, 
2004. 39(3): p. 187-95. 
56. Sboros, V., et al., Absolute measurement of ultrasonic backscatter from single 
microbubbles. Ultrasound Med Biol, 2005. 31(8): p. 1063-72. 
57. Sun, Y., et al., Observation of contrast agent response to chirp insonation with a 
simultaneous optical-acoustical system. IEEE Trans Ultrason Ferroelectr Freq 
Control, 2006. 53(6): p. 1130-7. 
58. Dayton, P.A., et al., Optical and acoustical dynamics of microbubble contrast 
agents inside neutrophils. Biophysical Journal, 2001. 80(3): p. 1547-1556. 
59. Leighton, T., The acoustic bubble. 1994, London: Academic Press. 
60. Fyrillas, M.M. and A.J. Szeri, Dissolution or Growth of Soluble Spherical 
Oscillating Bubbles. Journal of Fluid Mechanics, 1994. 277: p. 381-407. 
61. Blake, F., The onset of cavitation in luquids. I. Cavitation threshold sound 
pressures in water as a function of temperature and hydrostatic pressure, Harvard 
university Acoustic Research Laboratory Technical Memorandum p. 1-52. 
62. Frinking, P.J.A., et al., Ultrasound contrast imaging: Current and new potential 
methods. Ultrasound in Medicine and Biology, 2000. 26(6): p. 965-975. 
63. de Jong, N., et al., Optical imaging of contrast agent microbubbles in an 
ultrasound field with a 100-MHz camera. Ultrasound in Medicine and Biology, 
2000. 26(3): p. 487-492. 
64. Dayton, P.A., et al., Optical and acoustical observations of the effects of 
ultrasound on contrast agents. Ieee Transactions on Ultrasonics Ferroelectrics and 
Frequency Control, 1999. 46(1): p. 220-232. 
65. Morgan, K.E., et al., Experimental and theoretical evaluation of microbubble 
behavior: Effect of transmitted phase and bubble size. Ieee Transactions on 
Ultrasonics Ferroelectrics and Frequency Control, 2000. 47(6): p. 1494-1509. 
 116
66. Caskey, C.F., et al., Direct observations of ultrasound microbubble contrast agent 
interaction with the microvessel wall. Journal of the Acoustical Society of 
America, 2007. 122(2): p. 1191-1200. 
67. Vanliew, H.D. and M.E. Burkard, Behavior of Bubbles of Slowly Permeating Gas 
Used for Ultrasonic-Imaging Contrast. Investigative Radiology, 1995. 30(5): p. 
315-321. 
68. Kabalnov, A., et al., Dissolution of multicomponent microbubbles in the 
bloodstream: 1. Theory. Ultrasound in Medicine and Biology, 1998. 24(5): p. 
739-749. 
69. de Jong, N., et al., Ultrasonic characterization of ultrasound contrast agents. 
Medical & Biological Engineering & Computing, 2009. 47(8): p. 861-873. 
70. Duncan, P.B. and D. Needham, Test of the Epstein-Plesset model for gas 
microparticle dissolution in aqueous media: Effect of surface tension and gas 
undersaturation in solution. Langmuir, 2004. 20(7): p. 2567-2578. 
71. Cable, M. and J.R. Frade, The Influence of Surface-Tension on the Diffusion-
Controlled Growth or Dissolution of Spherical Gas-Bubbles. Proceedings of the 
Royal Society of London Series a-Mathematical Physical and Engineering 
Sciences, 1988. 420(1859): p. 247-265. 
72. Barnhart, J., et al., Characteristics of Albunex: air-filled albumin microspheres 
for echocardiography contrast enhancement. Invest Radiol, 1990. 25 Suppl 1: p. 
S162-4. 
73. Wheatley, M.A. and S. Singhal, Structural Studies on Stabilized Microbubbles - 
Development of a Novel Contrast Agent for Diagnostic Ultrasound. Reactive 
Polymers, 1995. 25(2-3): p. 157-166. 
74. Wang, W.H., C.C. Moser, and M.A. Wheatley, Langmuir trough study of 
surfactant mixtures used in the production of a new ultrasound contrast agent 
consisting of stabilized microbubbles. Journal of Physical Chemistry, 1996. 
100(32): p. 13815-13821. 
75. Singhal, S., C.C. Moser, and M.A. Wheatley, Surfactant-Stabilized Microbubbles 
as Ultrasound Contrast Agents - Stability Study of Span-60 and Tween-80 
Mixtures Using a Langmuir Trough. Langmuir, 1993. 9(9): p. 2426-2429. 
 117
76. Bjerknes, K., et al., Preparation of polymeric microbubbles: formulation studies 
and product characterisation. International Journal of Pharmaceutics, 1997. 
158(2): p. 129-136. 
77. Unger, E.C., et al., Local drug and gene delivery through microbubbles. Prog 
Cardiovasc Dis, 2001. 44(1): p. 45-54. 
78. Kim, D.H., A.L. Klibanov, and D. Needham, The influence of tiered layers of 
surface-grafted poly(ethylene glycol) on receptor-ligand-mediated adhesion 
between phospholipid monolayer-stabilized microbubbles and coated class beads. 
Langmuir, 2000. 16(6): p. 2808-2817. 
79. AlkanOnyuksel, H., et al., Development of inherently echogenic liposomes as an 
ultrasonic contrast agent. Journal of Pharmaceutical Sciences, 1996. 85(5): p. 
486-490. 
80. Demos, S.M., et al., In vivo targeting of acoustically reflective liposomes for 
intravascular and transvascular ultrasonic enhancement. Journal of the American 
College of Cardiology, 1999. 33(3): p. 867-875. 
81. Huang, S.L. and R.C. MacDonald, Acoustically active liposomes for drug 
encapsulation and ultrasound-triggered release. Biochimica Et Biophysica Acta-
Biomembranes, 2004. 1665(1-2): p. 134-141. 
82. Pu, G., M.L. Longo, and M.A. Borden, Effect of microstructure on molecular 
oxygen permeation through condensed phospholipid monolayers. Journal of the 
American Chemical Society, 2005. 127(18): p. 6524-6525. 
83. Borden, M.A. and M.L. Longo, Dissolution behavior of lipid monolayer-coated, 
air-filled microbubbles: Effect of lipid hydrophobic chain length. Langmuir, 2002. 
18(24): p. 9225-9233. 
84. Kim, D., Mechanical Properties, Microstructure, and Specific Adhesion of Phospholipid 
Monolayer-Coated Microbubbles. 1999, Duke University. 
85. Torchilin, V.P., PEG-based micelles as carriers of contrast agents for different 
imaging modalities. Advanced Drug Delivery Reviews, 2002. 54(2): p. 235-252. 
 118
86. Definity Data sheet. September 2009, Global Medical Solutions Ltd: Auckland, 
New Zealand. 
87. Lindner, J.R., et al., Noninvasive imaging of inflammation by ultrasound detection 
of phagocytosed microbubbles. Circulation, 2000. 102(5): p. 531-538. 
88. Lindner, J.R., et al., Noninvasive ultrasound imaging of inflammation using 
microbubbles targeted to activated leukocytes. Circulation, 2000. 102(22): p. 
2745-2750. 
89. Lindner, J.R., et al., Microbubble persistence in the microcirculation during 
ischemia/reperfusion and inflammation is caused by integrin- and complement-
mediated adherence to activated leukocytes. Circulation, 2000. 101(6): p. 668-
675. 
90. Villanueva, F.S., et al., Microbubbles targeted to intercellular adhesion molecule-
1 bind to activated coronary artery endothelial cells. Circulation, 1998. 98(1): p. 
1-5. 
91. Halliwell, B., Reactive Oxygen Species in Living Systems - Source, Biochemistry, 
and Role in Human-Disease. American Journal of Medicine, 1991. 91: p. S14-
S22. 
92. Blomley, M., et al., Stimulated acoustic emission in liver parenchyma with 
Levovist. Lancet, 1998. 351(9102): p. 568-568. 
93. Forsberg, F., et al., Tissue-specific US contrast agent for evaluation of hepatic 
and splenic parenchyma. Radiology, 1999. 210(1): p. 125-132. 
94. Leen, E., et al., Prospective multicenter trial evaluating a novel method of 
characterizing focal liver lesions using contrast-enhanced sonography. American 
Journal of Roentgenology, 2006. 186(6): p. 1551-1559. 
95. Schneider, M., et al., Gray-scale liver enhancement in VX2 tumor-bearing rabbits 
using BR14, a new ultrasonographic contrast agent. Investigative Radiology, 
1997. 32(7): p. 410-417. 
 119
96. Tarantino, L., et al., Diagnosis of benign and malignant portal vein thrombosis in 
cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-
enhanced US, and fine-needle biopsy. Abdom Imaging, 2006. 31(5): p. 537-44. 
97. Berry, J.D. and P.S. Sidhu, Microbubble contrast-enhanced ultrasound in liver 
transplantation. Eur Radiol, 2004. 14 Suppl 8: p. P96-103. 
98. Rossi, S., et al., Contrast-enhanced versus conventional and color Doppler 
sonography for the detection of thrombosis of the portal and hepatic venous 
systems. AJR Am J Roentgenol, 2006. 186(3): p. 763-73. 
99. Quaia, E., et al., Characterization of focal liver lesions with contrast specific US 
modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic 
performance and confidence. Radiology, 2004. 232(2): p. 420-430. 
100. Kim, S.H., et al., Value of contrast-enhanced sonography for the characterization 
of focal hepatic lesions in patients with diffuse liver disease: receiver operating 
characteristic analysis. AJR Am J Roentgenol, 2005. 184(4): p. 1077-84. 
101. Nicolau, C., et al., Importance of evaluating all vascular phases on contrast-
enhanced sonography in the differentation of benign from malignant focal liver 
lesions. American Journal of Roentgenology, 2006. 186(1): p. 158-167. 
102. Nicolau, C., et al., Evaluation of hepatocellular carcinoma using SonoVue, a 
second generation ultrasound contrast agent: correlation with cellular 
differentiation. European Radiology, 2004. 14(6): p. 1092-1099. 
103. Quaia, E., et al., Comparison of visual and quantitative analysis for 
characterization of insonated liver tumors after microbubble contrast injection. 
American Journal of Roentgenology, 2006. 186(6): p. 1560-1570. 
104. Fretland, D.J., et al., Temporal relationships of cytokine production in mouse non-
lethal sepsis: Effect of nitric oxide synthase inhibitors. Inflammation Research, 
1997. 46: p. S155-S156. 
105. Rubin, M.B., R.M. Noyes, and K.W. Smith, Oscillations and Instabilities in 
Chemical-Systems .74. Gas-Evolution Oscillators .9. A Study of the Ammonium 
Nitrite Oscillator. Journal of Physical Chemistry, 1987. 91(6): p. 1618-1622. 
 120
106. Gerth, W.A. and E.A. Hemmingsen, Heterogeneous Nucleation of Bubbles at 
Solid-Surfaces in Gas-Super-Saturated Aqueous-Solutions. Journal of Colloid and 
Interface Science, 1980. 74(1): p. 80-89. 
107. Bowers, P.G., et al., Supersaturation Limit for Homogeneous Nucleation of 
Oxygen Bubbles in Water at Elevated Pressure - Superhenry-Law. Journal of 
Physical Chemistry, 1995. 99(23): p. 9632-9637. 
108. Hey, M.J., A.M. Hilton, and R.D. Bee, The Formation and Growth of Carbon-
Dioxide Gas-Bubbles from Supersaturated Aqueous-Solutions. Food Chemistry, 
1994. 51(4): p. 349-357. 
109. Zalipsky, S., et al., Thiolytically cleavable dithiobenzyl urethane-linked polymer-
protein conjugates as macromolecular prodrugs: Reversible PEGylation of 
proteins. Bioconjugate Chemistry, 2007. 18(6): p. 1869-1878. 
110. Kakade, M.L. and I.E. Liener, Determination of Available Lysine in Proteins. 
Analytical Biochemistry, 1969. 27(2): p. 273-&. 
111. Re, R., et al., Antioxidant activity applying an improved ABTS radical cation 
decolorization assay. Free Radical Biology and Medicine, 1999. 26(9-10): p. 
1231-1237. 
112. Bird, R.B., W.E. Stewart, and E.N. Lightfoot, Transport phenomena. 2nd, Wiley 
international ed. 2002, New York: J. Wiley. xii, 895 p. 
113. Ferrell, R.T. and Himmelbl.Dm, Diffusion Coefficients of Nitrogen and Oxygen in 
Water. Journal of Chemical and Engineering Data, 1967. 12(1): p. 111-&. 
114. Cadenas, E. and K.J.A. Davies, Mitochondrial free radical generation, oxidative 
stress, and aging. Free Radical Biology and Medicine, 2000. 29(3-4): p. 222-230. 
115. Goldstein, S., D. Meyerstein, and G. Czapski, The Fenton Reagents. Free Radical 
Biology and Medicine, 1993. 15(4): p. 435-445. 
116. Herbert, E., S. Balibar, and F. Caupin, Cavitation pressure in water. Physical 
Review E, 2006. 74(4): p. -. 
 121
117. Zheng, Q., et al., Liquids at Large Negative Pressures - Water at the 
Homogeneous Nucleation Limit. Science, 1991. 254(5033): p. 829-832. 
118. Church, C.C., Spontaneous homogeneous nucleation, inertial cavitation and the 
safety of diagnostic ultrasound. Ultrasound in Medicine and Biology, 2002. 
28(10): p. 1349-1364. 
119. Apfel, R.E. and C.K. Holland, Gauging the Likelihood of Cavitation from Short-
Pulse, Low-Duty Cycle Diagnostic Ultrasound. Ultrasound in Medicine and 
Biology, 1991. 17(2): p. 179-185. 
120. Talanquer, V. and D.W. Oxtoby, Nucleation of Bubbles in Binary Fluids. Journal 
of Chemical Physics, 1995. 102(5): p. 2156-2164. 
121. Church, C.C., Spontaneous homogeneous nucleation, inertial cavitation and the 
safety of diagnostic ultrasound. Ultrasound Med Biol, 2002. 28(10): p. 1349-64. 
122. Eller, A. and H.G. Flynn, Rectified Diffusion during Nonlinear Pulsations of 
Cavitation Bubbles. Journal of the Acoustical Society of America, 1965. 37(3): p. 
493-&. 
123. Borden, M.A., et al., Surface phase behavior and microstructure of lipid/PEG-
emulsifier monolayer-coated microbubbles. Colloids and Surfaces B-
Biointerfaces, 2004. 35(3-4): p. 209-223. 
124. Hettiarachchi, K., et al., On-chip generation of microbubbles as a practical 
technology for manufacturing contrast agents for ultrasonic imaging. Lab on a 






JOHN KANGCHUN PERNG 
 
 
John received a B.S. in Electrical Engineering and Computer Science from the 
University of California Berkeley in 2001, and a M.S. in Electrical and Computer 
Engineering from Georgia Institute of Technology in 2006 before pursuing a doctorate in 
Bioengineering at Georgia Institute of Technology. 
 
